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ABSTRACT
SARZYNSKI, M. A., T. K. RICE, J.-P. DESPRÉS, L. PÉRUSSE, A. TREMBLAY, P. R. STANFORTH, A. TCHERNOF, J. L. BARBER,
F. FALCIANI, C. CLISH, J. M. ROBBINS, S. GHOSH, R. E. GERSZTEN, A. S. LEON, J. S. SKINNER, D. C. RAO, and C. BOUCHARD.
The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers. Med. Sci. Sports Exerc., Vol. 54, No. 5, pp. S1-S43, 2022. The aim of the HERITAGE Family Study was to investigate individual
differences in response to a standardized endurance exercise program, the role of familial aggregation, and the genetics of response levels
of cardiorespiratory fitness and cardiovascular disease and diabetes risk factors. Here we summarize the findings and their potential implications for cardiometabolic health and cardiorespiratory fitness. It begins with overviews of background and planning, recruitment,
testing and exercise program protocol, quality control measures, and other relevant organizational issues. A summary of findings is then
provided on cardiorespiratory fitness, exercise hemodynamics, insulin and glucose metabolism, lipid and lipoprotein profiles, adiposity
and abdominal visceral fat, blood levels of steroids and other hormones, markers of oxidative stress, skeletal muscle morphology and
metabolic indicators, and resting metabolic rate. These summaries document the extent of the individual differences in response to a standardized and fully monitored endurance exercise program and document the importance of familial aggregation and heritability level for
exercise response traits. Findings from genomic markers, muscle gene expression studies, and proteomic and metabolomics explorations are reviewed, along with lessons learned from a bioinformatics-driven analysis pipeline. The new opportunities being
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pursued in integrative -omics and physiology have extended considerably the expected life of HERITAGE and are being discussed
in relation to the original conceptual model of the study. Key Words: EXERCISE GENOMICS, HERITABILITY, EXERCISE TRAINING,
CARDIOMETABOLIC RISK FACTORS, EXERCISE AND GENE EXPRESSION, EXERCISE AND PROTEOMICS, EXERCISE AND
METABOLOMICS, EXERCISE AND BIOINFORMATICS

T

he aim of this article is to summarize the findings of the
HERITAGE (HEalth, RIsk factors, exercise Training
And GEnetics) Family Study and their potential implications for cardiometabolic health and exercise performance.
HERITAGE has contributed substantially to our understanding of adaptation to exercise and endurance training over the
last 25 yr. It started as a collaborative endeavor among scientists from five research institutions in the United States and
Canada. Over the years, investigators from institutions around
the world have joined the effort to use HERITAGE data to address novel questions of scientific interest.
Scientists who have been involved in the early phases of the
study or are currently leveraging the biobank and data of HERITAGE to address underlying biological mechanisms have undertaken the present review. The review covers foundational
topics such as background and planning, recruitment, testing
and exercise program protocol, panel of quality control measures, and other relevant issues. This is followed by a review
of the findings on cardiometabolic traits, including adiposity
and specific fat depots, cardiorespiratory fitness, exercise hemodynamics, insulin and glucose metabolism, lipid and lipoprotein profile, blood levels of steroids and other hormones,
markers of oxidative stress, skeletal muscle morphology and
metabolic indicators, and resting metabolic rate (RMR). Subsequently, reviews of findings arising from genomic markers, muscle gene expression studies, and proteomic and metabolomic explorations are provided, along with lessons learned from a bioinformatics pipeline. Finally, an overview of the strengths and
limitations of the study, and considerations on new opportunities
offered by advances in -omics and bioinformatics are offered.

Background. In a series of experiments performed in the
laboratory of C. Bouchard (CB) at Laval University, Quebec,
Canada, during the 1980s, two important conclusions were
reached. The first was that there were large interindividual differences in the response level to a standardized exercise program at a given dose (1–6). The second was that there was
strong indication of a genetic component to the variation in human trainability (4,6,7). Based on the aforementioned observations, it became evident that a major exercise training study
encompassing a substantial number of subjects from nuclear
families was necessary to test the genetic hypothesis more
thoroughly. To this end, CB established a team of seasoned
investigators who agreed to work together in the context of
a research consortium. They included Arthur S. Leon (ASL)
(University of Minnesota), D. C. Rao (DCR) (Washington
University), James S. Skinner (JSS) (initially at Arizona State
University and then at Indiana University), and the late Jack H.
Wilmore (JHW) (University of Texas at Austin).
Historical notes. The team began planning the study in
1988 and a series of meetings were held to prepare an application to the National Institutes of Health. The National Heart,
Lung and Blood Institute (NHLBI) expressed an interest in
the proposed research, and Dr. Millicent Higgins from the Division of Epidemiology and Clinical Applications came forward to provide guidance for a multicenter grant application
involving American and Canadian investigators. Our grant application was reviewed in June 1990, and a revision went to a
Special Review Committee in May 1991; the latter received an
excellent score and was recommended for funding. Dr. Claude
Lenfant, Director of NHLBI, and Dr. Higgins met with CB to

FIGURE 1—The 1992 model integrating the various components of HERITAGE. Subjects were measured in the sedentary state and after the exercise program intervention. Cardiorespiratory fitness, exercise hemodynamics, and subsets of cardiometabolic and diabetic risk factors were monitored. Differences
between Blacks and Whites were investigated. Studies on genetic and nongenetic determinants of human variability in the sedentary state and in response to
endurance exercise training were pursued.
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TABLE 1. Number of families, men, women, and total subjects at baseline and posttraining
in the HERITAGE Family Study.
Posttraininga

Baseline
Ancestry
Whites
Blacks
Total

Families

Men

Women

Total

Families

Men

Women

Total

101
117
218

262
117
379

267
209
476

529
326
855

99
105
204

233
87
322

250
172
422

483
259
742

a

Posttraining numbers include only the subjects who were classified as completers having
completed at least 57 (95%) of the 60 exercise training sessions.

THE HERITAGE FAMILY STUDY: A REVIEW

and other general information regarding the study can be found
at www.HeritageFamilyStudy.com.

PROTOCOL AND QUALITY
CONTROL MEASURES
The HERITAGE Family Study enrolled a total of 855 individuals from 101 two-generation nuclear families of European
ancestry (hereafter Whites), each with both biological parents
and at least two offspring, and from 117 families of African
ancestry (hereafter Blacks) (Table 1). The final sample at baseline included a total of 529 White and 326 Black individuals.
Participants were within 17–65 yr of age, “sedentary” for at
least 3 months before the study, and otherwise in good health.
They were evaluated before and after a 20-wk standardized
training program, providing an opportunity to assess familial
aggregation of responsiveness to regular exercise (8).
Families were recruited from media (newspapers, TV, radio),
posted advertisements, personal contacts, and institutional communication services. Telephone and mailed questionnaires were
used for initial eligibility screening. All potential families
underwent an orientation session to explain the study and answers questions. Participants were compensated up to $1000
in incremental payments for successful completion of the
study (i.e., after completing the 20-wk training program, after
completing baseline and posttraining battery of tests). The
study was approved by each participating institution’s institutional review board. Written informed consent was obtained
from each study participant, including permission to use individual cell lines, DNA, and collected specimens for the initial
project and future collaborative studies.
The recruitment went smoothly for the families of Whites,
as more than 90% of the families included both parents and
three or more offspring. Recruiting similar types of families
for participants who self-identified as Black was challenging.
This led to a revision of the recruitment requirements for the
latter families, which was approved by the HERITAGE Steering
Committee, the HERITAGE Advisory Board, and NHLBI. The
priority shifted to the recruitment of trios and pairs of first degree
relatives by descent in Black communities at all HERITAGE
sites. This revised approach worked well in the end, as we were
able to enroll 326 Black adults from 117 families (Table 1). It has
been brought to our attention that the description 27 yr ago of
the challenge we were facing in the recruitment of families of
African ancestry in the first HERITAGE paper devoted to
aims, design, and measurement protocols of the study (8)
was offensive to some. We agree, and in retrospect, we should
have used a more sensitive description of the situation.
The initial screening included a health history, physical examination, a resting electrocardiogram (ECG), and an exercise
test with ECG monitoring. At baseline, participants completed
a health questionnaire, including habits relating to smoking
and alcohol consumption; the ARICBaecke Physical Activity
Questionnaire (9,10); the Willett Food Frequency Questionnaire
to assess usual food nutrient patterns (11); the Minnesota Eating
Pattern Assessment Tool (EPAT) to evaluate dietary fat sources
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discuss the project funding and to ask for an expansion of the
research to a substantial sample of African American families.
The budget was adjusted accordingly, and the project was approved for funding (five coordinated R01 grants to CB, ASL,
DCR, JHW, and JSS) with a start date of September 1992
(phase 1). Data collection began in February 1993 and was
completed in the spring of 1997. The five grants were renewed
from 1997 to 2000 (phase 2) and from 2001 to 2003 (phase 3).
The grants for the two sites (CB and DCR) with expertise in
genetics were renewed from 2006 to 2010 (phase 4).
Aim of HERITAGE. The aim of the HERITAGE research
consortium was to investigate the magnitude of the individual
differences in response to a standardized endurance exercise
program, the importance of familial aggregation, and the genetics
of the response levels of cardiorespiratory fitness and cardiovascular disease and diabetes risk factors. Figure 1 depicts a schematic of the initial conceptual model underlying HERITAGE.
Organization of the research consortium. The HERITAGE Family Study was led by a Steering Committee composed of the five principal investigators (CB (Chair), DCR,
ASL, JHW, and JSS) and the Project Director (Jacques Gagnon
from 1992 to 1999 and Tuomo Rankinen from 1999 to 2012).
An administrator (Jean-Paul Albert) supported the work of the
Steering Committee from 1992 to 1999 (Supplementary Table S1,
Supplemental Digital Content, Appendix, http://links.lww.
com/MSS/C482). An Advisory Board supported and advised
the Steering Committee (Supplementary Table S2, Supplemental Digital Content, Appendix, http://links.lww.com/MSS/
C482). During phase 1, the most demanding period of the project, the research was organized around a Consortium Coordinating Center (Laval University), a Data Coordinating Center
(Washington University), four Clinical Centers responsible for
recruitment, testing, and training of subjects (Arizona State University and then Indiana University, Laval University, University of Minnesota, and University of Texas at Austin), and four
core laboratories (lipids, steroid hormones, glucose-insulin–
related traits, and cell lines) located at Laval University. The
leadership of these HERITAGE units and their personnel is
identified in Supplementary Table S3 (Supplemental Digital
Content, Appendix, http://links.lww.com/MSS/C482). By 2021,
more than 200 peer-reviewed articles have been published
from the HERITAGE Family Study. Most of these articles
were based solely on HERITAGE data. In other publications,
HERITAGE contributed data along with multiple other cohorts
mainly in the context of multicenter genome-wide association
studies (GWAS). A list of all HERITAGE-based publications

TABLE 2. List of the concomitant and behavioral variables available in the HERITAGE Family
Study.
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Phenotype
Age, sex, and ethnicity
Medical history: previous diseases and physical
examination
Personal history: medications, smoking, alcohol
consumption, level of education, occupation,
sleeping habits
Family history: myocardial infarction, other
cardiovascular disease, stroke, hypertension,
hypercholesterolemia, obesity, diabetes,
cancer
Menstrual cycle: age at menarche, menstrual
status (premenopausal and
postmenopausal), number of pregnancies,
babies over 9 lb, estrogen, and PROG
replacement
Physical activity habits: leisure time index, work
index, sports index
EPAT: Score section I and section II
Food frequency questionnaire
Anxiety levels

Baseline Midtraining Posttraining
x
x
x

x

x

x

x

x

x
x
x
x

x

x
x

(12,13); a menstrual history; and a detailed family history questionnaire (Table 2). The health habit and EPAT questionnaires
were repeated during midtraining (week 10). Participants were
instructed at the beginning and at midtraining to not change their
baseline health habits. The health habit and EPAT questionnaires
were administered again at the end of training (week 20).
Panel of Tests and Measurements
Anthropometric and body composition measurements were
made before and after training, as described elsewhere (14).
Measurements included standing height, body mass, skinfold
thicknesses at eight different sites, and waist circumference
(see Ref. [8]). Underwater weighing (the gold standard measure of body composition at the time) was performed in the
postabsorptive state before and after training to determine
body density, fat mass (FM), fat-free mass, and relative body
fat using sex- and ethnic-specific equations (15). Abdominal
visceral and subcutaneous fat were quantified before and after
training by computed tomography (CT) (16). Scans were taken
between the fourth and fifth lumbar vertebrae (L4–L5 space)
(14). Subjects were examined in the supine position, with arms
stretched above their heads. Total and visceral (AVF) abdominal fat areas (in cm2) were calculated by delineating those areas
with an electronic graph pen and then computing the adipose
tissue surfaces by using an attenuation range of −30 to −190
Hounsfield units. The abdominal subcutaneous fat area was calculated as the difference between the total and visceral fat areas.
Resting blood pressure (BP) measurements were made twice
on separate days before the start of exercise training and at 24and 72 h after training. Subjects were tested before 11:00 A.M.
in the postabsorptive state with no caffeine-containing beverages and tobacco products for at least 2 h before measurements.
BP was determined using a properly fitted cuff connected to a
Colin STBP-780 automated unit (17).
To measure plasma lipid and lipoprotein levels, blood samples were collected in the morning after a 12-h fast, kept on ice

S4

Official Journal of the American College of Sports Medicine

until centrifugation, and then stored at 4°C until analyzed
within 10 d (18). Total cholesterol (TC) and triglycerides (TG)
levels were determined in plasma and lipoprotein fractions
(VLDL, HDL, LDL) by enzymatic methods using the Technicon
RA-1000 analyzer plasma. Apolipoprotein (Apo) B and ApoA-I
concentrations were measured, and those of LDL cholesterol
(LDL-C), LDL-TG, and VLDL-ApoB were calculated. The
cholesterol content of HDL2 and HDL3 subfractions was also
determined. ApoE phenotype was measured by an isoelectrofocusing
method. Lipoprotein lipase (LPL) and hepatic-TG lipase (HL)
activities were measured in plasma obtained from 12-h fasted
subjects, 10 min after intravenous injection of heparin (60 IU·kg−1
of body weight).
An intravenous glucose tolerance test (IVGTT) was performed in the morning after an overnight fast. Blood samples
were collected at 16 time points over 3 h to determine plasma
glucose, insulin, and connecting peptide (C-peptide) concentrations. The updated MINMOD model was used to quantify
the acute response to insulin, insulin sensitivity index (Si), disposition index, and other parameters (19).
The plasma steroid hormone profile was assayed, including
androstenedione (DELTA4), testosterone (TESTO), dihydrotestosterone (DHT), androsterone glucuronide (ADTG),
androstane-3α, 17β-diol glucuronide, pregnenolone (PREGE)
fatty acid esters, dehydroepiandrosterone and its fatty acid,
progesterone (PROG), 17-hydroxyprogesterone, cortisol (CORT),
aldosterone (ALDO), estradiol (E2), and dehydroepiandrosterone
sulfate. Table 3 summarizes the variables measured and the
posttraining timing of measurements. Three exercise cardiorespiratory fitness tests all on cycle ergometers were performed
before and after the exercise program. The first test was a ramp
protocol with increasing workload every 2 min leading to exhaustion and the first estimate of V̇O2max. The second test was
a submaximal test with workloads of 50 W and then 60% of
the power output (PO) at V̇O2max, each lasting 8 min in to obtain physiological data in steady state. The third test repeated
the conditions of the preceding submaximal tests, then
proceeded to a PO corresponding to 80% of V̇O2max, followed
by a progressively increasing workload until exhaustion and the
second estimate of V̇O2max. Resting and exercise BP, fasting insulin, glucose and C-peptide, lipid and lipoprotein profile, and
steroid hormone profile measurements were performed twice
before the exercise training program, as well as twice posttraining
(24 and 72 h after the last exercise session), as specified in
Table 3. The anthropometry, body composition, CT assessment
of abdominal fat, IVGTT, postheparin LPL and HL activities,
and the plasma levels of various substrates during exercise were
obtained only once before and once post training. Additional
traits measured in subsamples of the HERITAGE cohort were
performed once before and once after the exercise program.
Inclusion and Exclusion Criteria
Age. Participants outside 17–65 yr old were excluded to reduce potential complications from maturation at the low end
and aging at the high end.

http://www.acsm-msse.org

TABLE 3. List of phenotypes available in the HERITAGE Family Study.
Baseline
Phenotype

Test 1

Test 3

x
x

x
x

x
x
x

x
x
x

Test 4

x
x

x
x

x (24 h)
x

x (72 h)
x

x
x

x

x
x

x

x
x

x

x (24 h)

x (72 h)
x (72 h)

x

x

x (24 h)

x (72 h)

x
x
x

x
x

x
x

x
x
x

x
x
x
x
x
x

x
x
x
x (96 h)
x

24 h, 72 h, and 96 h refer to tests performed 24, 72, and 96 h after the last training session, respectively.
Three exercise tests were performed before and after training. First, a maximal cardiorespiratory fitness test was performed. It was a cycle ergometer test with increasing workload leading to
exhaustion and VO2max. The data from this test were used to compute the specific HR and PO needed for the exercise prescription of each participant. The second test was submaximal and
included exercising for 8 min at 50W followed by 8 min at the PO associated with 60% of VO2max. The last test repeated the conditions of the second test, followed by a workload corresponding
to 80% of VO2max, and then increasing workloads until exhaustion was reached to provide a second estimate of VO2max. In the post-training period, these tests were performed at 24, 48, and 72 h
following the last exercise training bout.

Activity level. All participants were required to be “sedentary”
at baseline. Sedentary was defined as no regular physical activity
(occurring no more than once a week) involving an energy expenditure of ≥7 METs for subjects 50 yr and older and ≥8 METs for
those younger than 50 yr over at least the previous 3 months.
Body mass index. Body mass index (BMI) was <40 kg·m−2
because of metabolic abnormalities and difficulty in exercising that is associated with extreme obesity. However, a few
subjects with a BMI of 40 kg·m−2 or more were included because it was determined that they could perform the exercise
and the testing program.
BP and medications. Resting BP was required to be
<160/100 mm Hg for two out of three readings. Individuals
on diuretic or antihypertensive drugs at the initial interview
were permitted to enter the study if they were free of hypertensive complications, their personal physician permitted them to
discontinue their medication(s), and their BP level met the
aforementioned criteria after at least 3 months off medication.
Subjects unable to be removed from their antihypertensive
treatment were excluded from the study.
Absence of significant medical conditions and diseases. A detailed medical history and physical examination
were conducted by a physician or a nurse practitioner under
the supervision of a physician after screening. For subjects with
suspicious symptoms or suggestive medical histories, their personal
physicians were asked to provide additional medical information,
test results, and hospital records before inclusion or exclusion.

THE HERITAGE FAMILY STUDY: A REVIEW

A past history and/or physical or laboratory finding of certain
medical conditions required exclusion from the study (8).
Exercise Testing Protocol
Three exercise tests were administered both before and after
training: maximal, steady-state submaximal, and submaximal–
maximal. All tests were performed on the same cycle ergometer
(Ergo-Metrics 800S from SensorMedics; different from the cycle ergometer used for the training program) in the sitting position at approximately the same time of day, with at least 48 h
difference between tests at baseline. The first test was to establish the participant’s V̇O2max, as well as to verify the normality
of the exercise ECG at baseline. The maximal test started at an
initial intensity of 50 W for 3 min and increased by 25 W every
2 min until volitional exhaustion. For older, smaller, or less fit
individuals, the test started at 40 W, with increases of 10–20 W
each 2 min thereafter. This was done in to increase the number
of stages they could complete before reaching maximum because
the results were used to select the PO for the subsequent exercise
tests (20). During the second test, participants exercised at 50 W
and at 60% V̇O2max, determined from the initial maximal test, for
8 min at each PO to measure steady-state ventilation (VE), V̇O2,
VCO2, respiratory exchange ratio (RER), systolic (SBP) and
diastolic (DBP) BP, heart rate (HR), cardiac output (Q̇), and
stroke volume (SV). During the third and final test, each participant repeated the submaximal steady-state exercise at 50 W
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Body fat and body composition
Weight, height, and BMI
FM and fat-free mass (underwater weighing)
Regional fat distribution and visceral fat
CT total, subcutaneous, and visceral fat
Sum of 8 skinfolds
Waist and hip girths
BP
Resting
Exercise at 50 W and at 60% and 80% V̇O2max
Insulin and glucose metabolism
IVGTT: Glucose, insulin, C-peptide
Fasting: Glucose, insulin, C-peptide
Lipids, lipoproteins, and lipases
Postheparin lipolytic activities: LPL and HL
Fasting lipid, lipoprotein, apolipoprotein profile
Steroids
Panel of androgens, estrogens plus SHBG
Cardiorespiratory endurance
Submaximal and maximal indicators of cardiorespiratory fitness
SV, cardiac output, and other hemodynamic indicators during exercise
Plasma protein, glucose, FFA, lactate at 50 W, 60% V̇O2max and 80% V̇O2max, and max
Additional phenotypes on subsamples
Leptin (resting and exercise)
Insulin-like growth factors 1 and 2
Homocysteine, cysteine, glutathione, cysteinyl glycine, folates, vitamins B6, and B12
LDL oxidation, TBARS, hemolysis, GSH-Px, α-tocopherol, β-carotene, retinol, phospholipid fatty acids, Lp(a)
Skeletal muscle fiber types, capillary density, enzymes
RMR

Posttraining
Test 2

Core Laboratories, Cell Lines, Biobank

TABLE 4. Overview of the 20-wk training program in HERITAGE.
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Weeks
2
2
2
2
2
2
2
6

Frequency
(Sessions per Week)

Intensity
(% V̇O2max)

Duration
(Minutes per Session)a

3
3
3
3
3
3
3
3

55
55
65
65
70
70
75
75

30
35
35
40
40
45
45
50

a

Does not include 5-min warm-up or 3-min cool-down.

and 60% V̇O2max of the second test, after which the PO was increased to 80% V̇O2max and then continued to increase until the
subject reached volitional exhaustion. In addition, a venous
catheter was inserted in the left arm to obtain blood samples
at rest, during exercise at 50 W and at 60% and 80% V̇O2max,
and immediately upon completion of the maximal test. Blood
samples were analyzed for glucose, free fatty acids, lactate, and
total proteins. Metabolic measurements and Q̇ (CO2 rebreathing
technique) were determined using a SensorMedics 2900 metabolic cart, BP with a Colin STBP-780 automated BP monitor,
and HR from the ECG. SV was derived from HR and Q̇.

Four core laboratories were established at Laval University
in Quebec, Canada, for assaying lipids, sex steroid hormones,
and glucose-insulin–related traits, and to establish cell lines.
Lymphoblastoid cell lines were established for each participant
to ensure a continuous source of DNA. Cell lines were obtained
by transformation of human lymphocytes with the Epstein–Barr
virus. Such cell lines grow well in culture, have an infinite life
span, and present chromosomal stability over years (21). The
procedure requires isolation of monocyte cells, transformation
with the virus, and cryopreservation of transformed cell lines.
Training of Personnel and Data Quality
Study personnel were centrally trained on recruitment, measurement, exercise testing, exercise training, and data entry using a detailed Manual of Procedures. Retraining of staff on measurement
protocols was implemented as needed at each clinical center under
the Project Director on a yearly basis. Appropriate training of new
personnel was provided when necessary. These actions were designed to maximize quality of all data acquired at each clinical
center and to minimize potential unwarranted data heterogeneity.

Exercise Training Protocol

Reproducibility, Clinical Center Differences, and
Drift over Time

The training protocol required a total of 60 training sessions,
three per week for 20 wk. All training sessions were held on-site
at the participating clinical centers. Each participant trained on a
cycle ergometer (Universal Aerobicycles, Cedar Rapids, IA)
using the same standardized training protocol at the four clinical
centers. Training intensity was adjusted for individual differences in V̇O2max and began at the HR associated with 55% of
baseline V̇O2max (derived from the first, maximal exercise test)
for 30 min for the first 2 wk. The intensity or duration of the
training sessions was increased every 2 wk, until subjects were
working at the HR associated with 75% of baseline V̇O2max for
50 min during the last 6 wk (Table 4). The PO of the cycle ergometer was adjusted to maintain each subject’s HR at the prescribed level; this was controlled by direct HR monitoring at all
times during all training sessions using the Universal Gym
Mednet (Cedar Rapids, IA) computerized system. All training
sessions were supervised on-site by trained personnel to ensure
that the equipment was working properly, and the participants
were compliant with the protocol. A total of 742 participants
completed at least 95% of the training sessions (57 sessions)
and were defined as “completers.”
Subjects were not allowed to exercise more than four sessions per week or less than one per week and could not get
ahead or fall behind by more than two sessions. Adherence
was monitored several times per week. If subjects were falling
behind, a plan was developed to bring them back on schedule
as soon as possible. In premenopausal women, tests and measurements were scheduled during the follicular phase of the
menstrual cycle. This required that some women exercised a
few or several more sessions until they had reached the proper
phase of their menstrual cycle.

As part of the quality control program of HERITAGE, plans
were made to quantify assay and measurement variability,
within-subject variability, potential clinical site differences,
and drift over time in protocol at each clinical center. As a control group was not deemed necessary by the investigators and
external reviewers given the primary aim of HERITAGE, the
quality control measures became particularly important and
useful. The metrics of these quality control measures have
been addressed in several publications (18,22–25), and they
are commented upon hereinafter in the various sections of this
article. Briefly, four approaches were used to assess assay and
measurement reproducibility and within-subject variability.
First, for all traits assayed from blood samples, the assay was
repeated on split samples from the same blood draw. In addition, the assays were performed twice on 5% of all samples selected at random. Second, for all variables that were measured
days apart, twice before and twice after the exercise program,
reliability coefficients (intraclass correlations), technical errors
(within-subject SD), and coefficients of variation (CV) (100 ×
SD/mean) could be computed across all subjects. Third, an additional 15 subjects meeting the inclusion criteria of the study
were recruited at each clinical center for the sole purpose of
being tested three times over 3 wk for most of the HERITAGE
panel of tests. Fourth, four subjects (a total of eight individuals
over the period) traveled to all four clinical centers in a random
order across three yearly cycles under the supervision of the
Project Director to take the full battery of tests and measurements at each clinical center.
Table 5 summarizes the test–retest data at baseline plus the
quality control study data on subjects measured three times over
3 wk. Intraclass correlations, technical errors, and CV are

S6

Official Journal of the American College of Sports Medicine

http://www.acsm-msse.org

TABLE 5. Reproducibility and technical error for selected traits as derived from the test–retest of the HERITAGE protocol at baseline and from a quality control substudy performed on subjects
measured three times within 3 wk across the four clinical centers.
Heritage Family Subjects (n Varies from 279 to 745)

Quality Control Substudy (n Varies from 55 to 60)

Intraclass Correlation Technical Error Coefficient of Variation (%) Intraclass Correlation Technical Error Coefficient of Variation (%)
1.00
0.89
0.99
0.93
0.88
0.95
0.95
0.94
0.95

0.1
6.1
53.4
0.8
5.4
119.9
0.21
0.06
8.1

0.95
0.90

1.9
0.3

0.96
0.97
0.97
0.97

955
673
4.1
11.7

0.2
4.4
3.6
5.9
2.9
5.1
4.7
6.2
15.4

1.0
0.79
0.98
0.95
0.88
0.96
0.93
0.94
0.95

0.7
6.5
62.2
0.7
3.7
136.9
0.24
0.06
7.6

13
23

0.95
0.92

1.8
0.2

16
18

0.94
0.92

11
15

0.98
0.99

868
801
3.6
11.9

0.2
6.1
3.5
4.5
2.0
4.7
6.0
6.0
14.7
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Body weight (kg)
HR 50 W (bpm)
V̇O2 at 60% max (mL O2·min−1)
Cardiac output at 60% max (L·min−1)
Max HR (bpm)
V̇O2 max (mL·min−1)
Cholesterol (mmol·L−1)
HDL-Chol (mmol·L−1)
LPL (nmol·min−1·mL−1)
TESTO (nmol·L−1)
Male
Female
DHEAS (nmol·L−1)
Male
Female
SHBG (nmol·L−1)
Male
Female

11
13
13
18
9
12

Adapted from Wilmore et al. (26), Wilmore et al. (27), Skinner et al. (20), Despres et al. (18), and He et al (28).

presented for a subset of variables to illustrate the various measurement domains of HERITAGE. Under both designs, the
three indicators of reproducibility can be considered highly satisfactory and well within values reported in the literature for
these types of measurements.
One aspect of the Quality Control Program was to verify periodically whether there were differences in measurements
across clinical sites (24–27). No substantive differences
among the four clinical centers were found. Likewise, there
were no substantive differences between Blacks and Whites
(23). Finally, data were interrogated across six time periods
of the data collection phase to verify whether there was any evidence of drift over time (22). None was detected.
General Overview of Statistical Analyses
In general, standard statistical methods (e.g., correlations, linear regressions, general linear models, t-tests) were used to assess the associations within and between phenotypes at baseline
and in response to exercise training. The specific procedures
used were specific to the research questions and tests being performed. Models were run in the total sample or stratified by
ethnic, sex, or age group, or post hoc analysis was used to determine differences between subgroups. In most HERITAGE individual studies, statistical significance was established at P < 0.05.
Thus, for any text hereafter referring to results from previously
published HERITAGE studies, particularly results related to
clinical phenotypes (i.e., non-omics variables), the term “significance” refers to P < 0.05, unless otherwise noted. Moreover, if
text states that a value “increased” or “decreased” without also
using the word “significant,” it should be assumed the increase/
decrease was significant unless otherwise noted.

EXERCISE, ADIPOSITY, AND FAT DEPOTS
The reproducibility of anthropometric and body composition
measures in HERITAGE was determined in 60 men and women
who completed the entire anthropometric and body composition
test battery on three different days within a period of 3 wk (26). A
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high degree of reproducibility was observed across all traits measured and at each of the clinical centers. For instance, intraclass
correlations ranged from 0.95 to 0.99 for anthropometric measures and from 0.97 to 1.00 for body composition measures, all
with low technical error variance; this suggests that it would be
possible to detect small changes in adiposity phenotypes in response to the endurance training program, with a view to investigate the genetic basis of these changes.
Baseline observations and effects of training. HERITAGE participants were slightly overweight, with average
baseline BMI values ranging from 24.9 ± 13.9 kg·m−2 in
White women to 27.9 ± 6.0 kg·m−2 in Black women (29). Significant ethnic differences were found for most adiposity phenotypes in women (but not in men), with higher values in
Black women than in White women. At baseline, higher values
of adiposity (sum of eight skinfolds, percent body fat, and FM)
were observed in men than in women. Both before and after
training, men had more AVF than women, Whites had more
than Blacks, and parents had about twice as much adiposity
as their offspring (14).
In response to training, there was only a marginal but significant decrease (delta values ± SE) in body weight (−0.2 ± 0.1 kg).
Decreases were also observed for the sum of skinfolds
(−6.2 ± 0.7 mm), waist girth (−0.9 ± 0.1 cm), percent body
fat (−0.8 ± 0.1), FM (−0.7 ± 0.1 kg), abdominal subcutaneous
fat (8.9 ± 1.1 cm2), AVF (−4.6 ± 0.6 cm2), and abdominal total
fat (−13.5 ± 1.4 cm2) in the total sample. The greatest changes
were observed for total FM and percent body fat (>3%) and
AVF (6%). There were several differences in training response
by sex and ethnicity but not by generation (parents vs children).
For example, reductions in FM and AVF were significantly
higher in men than in women. For the sum of eight skinfolds,
reductions were higher in Whites than in Blacks (14). After controlling for reductions in both BMI and waist girth, there were
significant reductions in FM, percent body fat, and all CT abdominal fat measurements in all sex–ethnic groups (30).
Familial aggregation studies. The topic of familial aggregation in the amount and distribution of fat was addressed
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FIGURE 2—CT measured AVF level at baseline adjusted for age, sex, and FM plotted by family rank among the families of European descent in HERITAGE. Dots within each bar represent individual values for each member of the given family. The dash within each bar is the mean AVF level of each family. For a given level of total adiposity, some families exhibit a mean adjusted AVF level of about 70 to 90 cm2, whereas others have AVF levels in the range of
120 to 150 cm2. Families are ranked by the mean-adjusted AVF level. A strong familial aggregation is observed with a heritability estimate of 47%. Adapted
with permission from Rice et al. (32).

(31,32). The heritability estimates for baseline AVF and FM in
86 White families reached 47% and 55%, respectively, with
no sex or generation differences in the familial correlations
for these measures (32). Figure 2 displays the CT AVF level adjusted for age, sex, and FM by family ranked on the basis of familial mean value. For a given level of total adiposity, there are families with low levels and others with high levels of visceral fat. The
heritability of AVF adjusted for age, sex, and FM was 47% (32).
Familial aggregation of the amount and distribution of subcutaneous fat (skinfold measures of trunk fat, extremity fat,
subcutaneous fat, and trunk to extremity fat ratio; waist circumference) at baseline and in response to training was examined in
483 White subjects from 99 families. Significant familial aggregation was found for all phenotypes measured at baseline and
for training-induced changes in trunk fat and waist circumference (31). The heritability estimates for baseline skinfold measures of fat ranged from 31% (total subcutaneous fat) to 51%
(waist circumference), whereas heritability estimates for the response phenotypes were lower (range, 14%–21%) and not significant for the change in waist circumference (31).

CARDIORESPIRATORY FITNESS
This section deals with indicators of maximal and submaximal exercise capacity, including V̇O2max, maximal and submaximal PO (at 60% and 80% V̇O2max), and V̇O2 at the ventilatory threshold (VO2VT). Because exercise testing was
done at four clinical centers, it was deemed important to determine the reproducibility of submaximal and maximal cycle ergometer exercise tests (as described previously). The withinsubject SD for repeated V̇O2max measures was 114 mL before

S8

Official Journal of the American College of Sports Medicine

training, 108 mL after training in >700 subjects, 137 mL for the
60 subjects tested three times in a period of 3 wk, and 115 mL in
8 traveling subjects tested four times, once at each clinical center, within a period of 2 wk. The CV for repeated measures
ranged from 4.1% to 5.0% and the intraclass correlations were
>0.96 (Refs. [20,27,33,34] and unpublished data). VO2VT
was also deemed satisfactorily reproducible with a test–retest
correlation of 0.83 (35).
In a study on the accuracy of commonly used age-based prediction equations for maximal HR (HRmax), Sarzynski et al.
(36) compared intrinsic (baseline or pretraining) HRmax obtained
in 762 subjects who underwent two separate maximal exercise
tests and where V̇O2max was directly measured, and compared
them with the Fox (220 − age) (37) and Tanaka (208 − 0.7 ×
age) (38) formulas. It was observed that the measured HRmax
was not highly correlated with estimated HRmax using these
formulas; the standard error of the estimate for the formulas
was ~11–12 bpm and largely consistent across sex and ethnicity. These findings highlight the limitations of using age to estimate HRmax.
Baseline observations. HERITAGE participants were
quite representative of sedentary populations of relevant age
groups. As depicted in Figure 3, V̇O2max (in milliliters of O2
per kilogram of body mass) averaged 33 in the sample of
493 Whites and 27 in 245 Blacks, with SDs ranging from
about 7 to 9. A wide range of cardiorespiratory fitness in the
sedentary state was observed in each ethnic group, with a range
of V̇O2max values extending from 15 to 55.
Training response. The steady-state HR and V̇O2 were
measured during cycle ergometer exercise tests before and
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FIGURE 3—Distribution of V̇O2max values at baseline in sedentary HERITAGE subjects.

after training (39). The HR associated with 55%, 65%, 70%,
and 75% of each subject’s pretraining V̇O2max was used to prescribe exercise intensity across the 20 wk of training. Using
the linear relationship between HR, V̇O2, and PO, PO was predicted for each of the 60 training sessions at the respective programmed HR. The average ratio of the actual training HR to
programmed HR was 0.99; that is, subjects typically trained
within 1–2 bpm of their prescribed HR. One could ask whether
minute-by-minute differences in the ratio of actual/predicted
PO influenced the V̇O2max training response. Secondary analysis showed that the training program significantly increased
mean V̇O2max across all actual/predicted PO classes (39). The
minute-by-minute difference between actual and predicted PO
accounted for 6% of the variance in gain in V̇O2max expressed
in milliliters of O2. (33).
The training program produced significant improvements in
V̇O2max (17%) and PO at 60% V̇O2max (26 W or 28%) (40).
There was wide interindividual variation in V̇O2max response,
with values ranging from −4.7% to +47.8% or −110 to +1100 mL
O2·min−1, as illustrated in Figure 4A.
The effects of exercise training intensity relative to the VT
on changes in PO (in watts) and VO2VT, as well as changes

in V̇O2max were evaluated (35). VT could be determined at
baseline and after training in 432 sedentary White and Black
men (n = 224) and women (n = 208). While training started
at a fixed intensity according to their V̇O2max (individual’s
HR corresponding to 55% of baseline V̇O2max), there was substantial variability in the training intensity relative to VT. The
range of participant’s V̇O2 at VT to V̇O2max (VT%V̇
O2max = VO2VT/V̇O2max) was 34% to 83%, reflecting differences in intrinsic fitness among participants despite everyone
being sedentary for at least 3 months before the study. In analyses that related baseline VT%V̇O2max to the changes in
VO2VT and V̇O2max after training, individuals who trained at
higher intensities (relative to VT) had greater improvements
in VO2VT after training. Overall, training intensity relative to
VT accounted for ~26% of the training effect on VO2VT,
whereas the absolute training intensity (measured in watts)
accounted for ~56% of the training effect. In contrast, there
was no effect in the training intensity relative to VT on V̇O2max
changes (35).
In a separate investigation, the changes in HR at a given percent of V̇O2max with training were investigated across the full
HERITAGE cohort and by age, sex, and ethnicity (42).

FIGURE 4—A, Distribution of the gains in V̇O2max expressed as a percentage of baseline V̇O2max level in the samples of Blacks and Whites. B, Familial
aggregation of the age and sex adjusted V̇O2max changes with the exercise program in the sample of Whites of European descent. Families are ordered
by the mean gain for all family members. The F ratio from the ANOVA shows that there are 2.5 times more variance between families than within families
(P = 0.0001). The horizontal blue line represents the mean gain for the whole group. The heritability of the V̇O2max training response reached 47%. Adapted
with permission from Bouchard et al. (41).
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TABLE 6. Maximal HR and V̇O2max training responses across HERITAGE categories of
participants.
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Group
All
Men
Women
Blacks
Whites
17–29 yr
30–49 yr
50–65 yr

n

Post Max HR (bpm)

ΔVO2max (mL O2)

ΔVO2max (%)

633
287
346
198
435
315
200
118

184 ± 13
183 ± 13
185 ± 12
184 ± 13
185 ± 13
191 ± 9
181 ± 11
172 ± 12

389 ± 204
444 ± 226
344 ± 172
366 ± 172
399 ± 217
397 ± 216
402 ± 189
244 ± 192

17 ± 9
16 ± 8
19 ± 10
18 ± 10
17 ± 9
17 ± 9
19 ± 9
18 ± 10

The 633 subjects retained for this table were completers with no missing data. Adapted with
permission from Skinner et al. (43).

Although HR decreased at the same absolute intensity (PO
in watts) with training, HR at the same relative intensity
(%V̇O2max) remained constant across all subgroups. These findings
in a large and diverse cohort were the first to show that frequent
testing and recalibration of HR relative to %V̇O2max during a
training program is unnecessary.
Age, sex, and ethnicity. The influence of age, sex, ethnicity, and initial fitness on the response of V̇O2max to training
was examined in 435 Whites and 198 Blacks (287 men and
346 women) (43). As expected, the average V̇O2max in milliliters
of O2 per minute increased significantly for all sex and ethnic
groups, but responses in men and women and Blacks and Whites
of all ages were slightly heterogeneous (Table 6). However, there
were no mean differences in the gains in V̇O2max expressed as a
percent of baseline levels across sex, ethnicity, and age classes.
The mean gain was 17% ± 9% (43). Blacks began with lower
values but had similar responses to those of Whites. Older subjects had a lower absolute change but a similar percent gain as
younger subjects. There were low, average, and high responders
at all ages, both sexes, both ethnic groups, and all levels of initial
V̇O2max. In the aggregate, age, sex, ethnicity, and initial fitness
had limited influence on V̇O2max response to standardized
training in a large heterogeneous sample of sedentary Black
and White men and women. It has been estimated that age,
sex, ethnicity, and baseline V̇O2max explain about 11% of
the variance in the response of V̇O2max to training, with age,
sex, and ethnicity, each explaining about 3% and baseline level
about 2% (33,44).
Familial aggregation. We reported that there was familial resemblance of intrinsic V̇O2max levels (i.e., V̇O2max in the
sedentary state), with 2.7 times more variance between families than within families based on 86 White families, and a heritability level of 51% for V̇O2max (in milliliters per minute) adjusted for age, sex, body mass, FM, and fat-free mass (45). A
significant spousal correlation in intrinsic V̇O2max (0.14 ≤ r ≤ 0.26)
was observed, consistent with results from prior studies (46,47).
Importantly, the variability in V̇O2max in the sedentary state
was best explained by a model in which maternal inheritance
accounted for about 60% of the heritability level instead of
the expected 50% (45).
Familial aggregation of three different measures of submaximal V̇O2 (V̇O2 at 60% and 80% V̇O2max) and submaximal
PO (PO at 60% and 80% V̇O2max) was investigated in White
participants at baseline (48). In analyses that adjusted for
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age, sex, and body mass, there were two to five times more
variance between than within families for these baseline traits,
with significant heritability estimates ranging from 48% to
74%, reflecting contributions from both genetic and shared environmental influences. These heritability estimates, as well as
the individual patterns of familial resemblance (e.g., spouse,
sibling, and parent–offspring correlations), were consistent
with results from prior studies of submaximal performance measures from the Quebec Family Study (49) and family participants
in the Canadian Fitness Survey (50).
The familial aggregation of the response of V̇O2max to training was examined in 481 adults from 98 White families. There
was 2.5 times more variance between families than within
families for V̇O2max response to training (41). This pattern of
familial clustering of V̇O2max trainability is illustrated in
Figure 4B. The most parsimonious familial correlation model
yielded a maximal heritability estimate of 47% for V̇O2max
response, with a maternal transmission accounting for slightly
more than half of the estimate (about 28%). Significant familial aggregation was observed for VT traits, with heritability
levels >50% for baseline measurements but more moderate
levels for training responses (heritability ranging from 22%
to 51%) (51). Heritability values ranged from 23% to 57%
for the training response of other indicators of submaximal
cardiorespiratory fitness (48). These findings are supported by
findings from monozygotic twin studies showing significant
within-pair correlations in training gains in submaximal exercise V̇O2 and PO after training (7,52).

EXERCISE AND HEMODYNAMICS
The data on exercise hemodynamics are derived from two
maximal exercise tests performed at baseline, two maximal
tests at 24 and 72 h after training, and submaximal exercise
at 50 W and 60% V̇O2max before and after the exercise program.
Measurements included VE, V̇O2, VCO2, RER, SBP, DBP,
HR, Q̇, and SV, plus plasma glucose, free fatty acids, lactate,
and total proteins. Cardiovascular, respiratory, and metabolic
adaptations to submaximal exercise were moderately to highly
reproducible, with CV values less than 9% and intraclass correlations greater than 0.80 (20,27). Reproducibility was generally better at higher PO. Except for SBP, DBP, and RER, cardiovascular, respiratory, and metabolic responses were also
highly reproducible during maximal exercise, with intraclass
correlations greater than 0.86 (20,27). Day-to-day variations
were modest, and reproducibility of submaximal and maximal
exercise values was comparable across the four clinical centers.
Baseline familial aggregation studies. A series of studies reported familial aggregation for intrinsic (baseline) cardiovascular variables and cardiorespiratory adaptation to training.
The heritability of resting SBP and DBP among 482 White participants from 99 HERITAGE families was quantified (53).
Heritability estimates for baseline SBP and DBP were 54%
and 41%, respectively, and are comparable to those from prior
studies (50,54,55) despite having lower CV values reflecting a
more uniform (i.e., sedentary) HERITAGE sample combined
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TABLE 7. Changes with the exercise program in hemodynamic variables during submaximal and maximal exercise in HERITAGE participants.
Variable

Pretraining Posttraining Change % Change
1029.7
120.2
95.9
11.3
9.2
1423.3
140.1
98.6
13.7
10.3
2343.4
184.9
18.2

994.9
108.8
99.8
10.7
9.4
1625.9
135.8
109.2
14.7
10.9
2725.9
184.3
20.1

−34.8
−11.4
3.9
−0.6
0.2
202.6
−4.3
10.6
1.0
0.6
382.6
−0.6
1.9

−3.2
−9.5
4.1
−5.31
2.2
15.3
−3.1
10.8
7.3
5.8
17.4
−0.3
10.4

Based on >631 subjects with complete data. All training effects are significant at P < 0.05.
Adapted from Wilmore et al. (61) and unpublished data.

with repeated baseline measurements. A subsequent investigation (56) showed substantially higher maximal heritability estimates for intrinsic resting SBP among African American families (68%), a population with limited existing data (57). Familial
aggregation of exercise SV and Q̇ at 60% V̇O2max was significant with moderate heritability levels (46% for both) (58).
Effects of the exercise program. Resting HR and BP
responses to exercise training were investigated according to
age, sex, and ethnicity. Small but consistent reductions in resting HR (−2.7 to −4.6 bpm) across subgroups were found (17).
Prior studies have produced conflicting data about the effect of
training on resting HR (59). In an ancillary study of HERITAGE, home-based HR monitoring was used to confirm the
accuracy of resting HR recorded in the laboratory (17). Resting
HR was measured on different days to determine intraindividual
variability. Furthermore, and distinct from results of prior studies
(60), there was no significant change in resting BP after training, which is likely explained by the lower baseline BP (118/
68 mm Hg) of the participants. In contrast, SBP, DBP, and
mean BP during submaximal exercise (at an absolute PO of
50 W) were generally lowered with training.
The response to training of SV, Q̇, and arteriovenous oxygen difference (a-V̇O2 diff) during submaximal and maximal
exercise was also evaluated (61) (Table 7). Steady-state V̇O2
at 50 W decreased only slightly (~3%) with training, likely
the result of improved ergometer cycling efficiency. As expected,
V̇O2 improved considerably at maximal PO (17.4%) and at
60% V̇O2 max (15.3%) with training. A significant decrease
in HR was observed during exercise at 50 W (mean reduction
of 11 bpm), but only a minor reduction of 4 bpm at 60%
V̇O2max, with no change in HRmax. Slight increases in SV (4%)
and a-V̇O2 diff (2%) were found at 50 W, which in combination
with the lower HR led to a slight decrease (−5%) in Q̇ (−5%).
During exercise at 60% V̇O2max, there were substantial increases
in SV (11%), Q̇ (7%), and a-V̇O2 diff (6%) with training. Whereas
HR at maximal exercise was unchanged, there were substantial
gains in Q˙ (10%) and V̇O2max (17%). These observations are
largely consistent with those from prior but smaller studies (62–65).
The role of menopause and hormone replacement on cardiovascular physiological traits was also examined (66). The
response of submaximal and maximal exercise cardiovascular

THE HERITAGE FAMILY STUDY: A REVIEW

Medicine & Science in Sports & Exercise®

S11

SUPPLEMENT

Downloaded from http://journals.lww.com/acsm-msse by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCyw
CX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 09/16/2022

V̇O2 at 50 W (mL·min−1)
HR 50 W (bpm)
SV 50 W (mL per beat)
Cardiac output 50 W (L·min−1)
a-V̇O2 diff 50 W (mL per 100 mL per beat)
V̇O2 at 60% V̇O2max (mL·min−1)
HR 60% (bpm)
SV 60% (mL per beat)
Cardiac output 60% (L·min−1)
a-V̇O2 diff 60% (mL per 100 mL per beat)
V̇O2max (mL·min−1)
Max HR (bpm)
Max cardiac output (L·min−1)

traits in premenopausal (n = 338) women, postmenopausal
women on hormone replacement therapy (HRT; n = 28), and
postmenopausal women not on HRT (n = 29) were explored.
In a novel finding, among all cardiovascular phenotypes examined, only baseline SBP during submaximal exercise (50 W)
was significantly lower among premenopausal women than
in postmenopausal women after adjustment for age. SBP during maximal but not submaximal exercise was significantly
lower among postmenopausal women on HRT than those
not taking HRT, a finding consistent with prior investigations
(67,68). This may be due to estrogen’s vasodilatory effects at
high exercise intensity. However, regular exercise-induced
improvements in exercise hemodynamic traits among women
are independent of age and menopausal or hormone replacement status.
Familial aggregation of response to the exercise
program. No familial aggregation was observed for resting
BP or HR in response to training in the full HERITAGE cohort
(53). However, comparing families who had elevated BP
(>135 and/or 80 mm Hg, SBP or DBP, respectively) in this
largely normotensive population with those who had normal
BP, there was a genetic component (35%–44%) to the variance in training-induced resting HR and SBP changes. These
findings are consistent with prior works (69) and further supported by a subsequent HERITAGE investigation (70), which
found that SBP and HR responses to training were characterized
by genetic contributions, but DBP responses seemed to be
largely independent of family lines.
The familial aggregation of training-induced changes in cardiorespiratory hemodynamic traits was considered in a series
of studies. Heritability estimates for the training-induced
changes in submaximal exercise V̇O2 and PO (60% or 80%
V̇O2max) were significant (range of 23% to 57%), but tended
to be lower than those for the baseline measures (48%–74%),
as detailed previously (48). In contrast to baseline measurements, there was minimal correlation among spouses in training
responses, suggesting that familial aggregation among these
traits was largely due to genetic influences. The effects of the
exercise program on HR and BP during submaximal exercise
among 99 White families (n = 481 participants) were investigated, and heritability estimates of HR at 50 W and 60%
V̇O2max were 34% and 29%, respectively, and 22% for SBP
at 50 W (71). These findings were independent of the effects
of age, sex, BMI, tobacco use, and baseline V̇O2max. In contrast, minimal heritability existed among DBP responses,
SBP at 60% V̇O2max, and all of the cardiovascular traits among
Black participants (all families with a total of 257 participants).
These findings were the first published analyses of familial aggregation of submaximal exercise BP and HR responses to an
endurance exercise training program but have not been replicated yet.
The association of cardiorespiratory fitness with risk of future coronary heart disease (CHD) was examined using a revised Framingham Heart Study algorithm (72). Compared
with the highest tertile, the lowest tertile of V̇O2max had a
62% greater risk of future CHD. Another study found that
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those with V̇O2max above the group median had lower levels
of FM, AVF, and total abdominal fat than those below for a
given BMI (30). These data suggest that lower total adiposity
and abdominal fat is a mean by which higher V̇O2max attenuates the health risks attributable to obesity.

EXERCISE, INSULIN, AND GLUCOSE
METABOLISM
Fasting plasma glucose and insulin were assayed in the
fasted state at baseline and 24 to 36 h after the last exercise
training session. An IVGTT was performed before and 24 h
after training with blood samples collected at 16 time points
over 3 h to determine plasma glucose, insulin, and connecting
peptide (C-peptide) concentrations, as described earlier (73).
The protocol did not include an injection of insulin or tolbutamide. From the MINMOD Millenium software (19), the following traits were derived: Si, AIRg, Di, Kg, and Sg. The Si
measures the ability of an increment in plasma insulin to enhance the net disappearance of glucose from plasma and is
used as a measure of insulin sensitivity. The acute insulin response to glucose (AIRg) is defined as the integrated area under the insulin curve between 0 and 10 min of the IVGTT and
represents a measurement of insulin response. The disposition
index (Di) was calculated as Si multiplied by AIRg and measures the ability of the pancreatic beta cells to compensate
for changes in insulin sensitivity. Kg is an estimate of the disappearance rate of plasma glucose calculated as the slope of
glucose from 10 to 60 min postintravenous glucose injection.
Glucose effectiveness (Sg) measures the ability of glucose, independent of change in plasma insulin, to increase glucose disposal and to suppress endogenous glucose output.
At baseline, mean Si was 61% higher in Whites than in
Blacks and 12% higher in women than in men (74) (Table 8).
Slight but clinically nonsignificant mean differences were seen
in fasting glucose. Mean fasting insulin was comparable between men and women but was higher in Blacks than in Whites.
The baseline AIRg was more than twice as high in Blacks as in
Whites. A positive correlation between Kg and glucose area below fasting glucose concentration was observed at baseline
(r = 0.49, P < 0.001). Age was significantly correlated with

baseline Si, Sg, AIRg, and Kg (r = −0.11, −0.13, −0.24, and
−0.33, respectively; all P < 0.01).
Effects of the exercise program. Mean Si increased by
10% (P < 0.006) after the training program, along with a 3%
(P < 0.001) decrease in AIRg, a nonsignificant 7% increase
in Di, an index of glucose homeostasis and ability of beta cell
to compensate for insulin resistance, a 11% (P < 0.002) increase in
Sg, a 3% (P < 0.02) increase in Kg, and a 7% (P < 0.02) decrease
in glucose area below fasting glucose concentration (74). Fasting
plasma glucose was unchanged with training. However, among
55 subjects with impaired fasting glucose (5.6–7.0 mmol·L−1 or
100–125 mg·dL−1) at baseline, 24 became normoglycemic in
response to the exercise program.
Interindividual variations in response to the exercise intervention were observed in IVGTT-derived measures (74). For
instance, AIRg increased 7% in the quartile of subjects displaying the lowest baseline glucose tolerance, whereas it decreased 14% in the upper quartile. Such a diverging insulin
response between the extreme quartiles of glucose tolerance
warrants further investigation regarding its underlying biology.
Another novel result was the significant reduction in area under
the glucose curve below fasting levels (74). This suggests that
training improves glucose regulation, not only by decreasing hyperglycemia but also by attenuating the risk of hypoglycemia.
In a secondary analysis, 38 HERITAGE Whites and 17 Blacks
were found to have an increase in fasting insulin in response to
the exercise program that was defined as adverse; that is, the
increase was 24 pmol·L−1 or more, which is twice the technical error for fasting insulin (75). Using the same definition of a
fasting insulin adverse response, it was found across six exercise intervention studies, encompassing 1687 subjects, that the
prevalence of an adverse fasting insulin response was 8.3%.
Adverse responders were found in all six studies. This is a
topic that has not received sufficient attention thus far and warrants further research because of its potential implications for
public health and type 2 diabetes management.
A significant interaction (P = 0.02) with sex was found for
the Si training response, with the mean increase in Si larger in
men (15%) than in women (5%). The mean increase in Si was
larger in Blacks (16%) than Whites (8%) and smaller in normal weight (6%) than in overweight (14%) and obese (15%)
participants, but these differences were not statistically

TABLE 8. Measures of insulin and glucose homeostasis at baseline and posttraining in HERITAGE by sex and ethnicity.
Total Participants (n ≥ 610)
Variables

Before

After

Women (n ≥ 321)
Before

After

Men (n ≥ 289)
Before

After

Blacks (n ≥ 178)
Before

After

Whites (n ≥ 432)
Before

After

5.1 ± 0.6
5.2 ± 0.6*
5.0 ± 0.6
5.1 ± 0.6*
5.2 ± 0.6
5.3 ± 0.6
5.1 ± 0.6
5.3 ± 0.7*
5.1 ± 0.6
5.1 ± 0.6**
Fasting glucose (mmol·L−1)
70.7 ± 50.4 64.2 ± 39.3* 68.5 ± 50.3 61.5 ± 36.0* 73.2 ± 50.5
67.1 ± 42.6* 81.9 ± 67.7 70.5 ± 43.3* 66.1 ± 40.5
61.6 ± 37.4*
Fasting insulin (pmol·L−1)
−4
−1
−1 a
Si (10 min ·[μU/mL] )
3.9 ± 2.9
4.1 ± 2.7*
4.1 ± 2.9
4.2 ± 2.6
3.6 ± 2.8
4.1 ± 2.7*
2.8 ± 2.3
3.1 ± 2.1*
4.3 ± 2.9
4.6 ± 2.8*
956 ± 1042 903 ± 933*
980 ± 1143 948 ± 1021
931 ± 924
855 ± 827* 1660 ± 1524 1570 ± 1348* 660 ± 524
623 ± 457*
AIRg (pmol·L−1 × 10 min)
−1
Sg (min )
0.02 ± 0.01 0.02 ± 0.01* 0.02 ± 0.01 0.02 ± 0.01* 0.02 ± 0.009 0.02 ± 0.01* 0.02 ± 0.01 0.02 ± 0.01* 0.02 ± 0.008 0.02 ± 0.01*
2713 ± 2411 2902 ± 2473* 2903 ± 2571 3053 ± 2714 2510 ± 2216 2741 ± 2177 3622 ± 3398 4015 ± 3348 2329 ± 1709 2435 ± 1804
Dib
1.70 ± 0.6
1.75 ± 0.6*
1.80 ± 0.6
1.84 ± 0.6
1.58 ± 0.6
1.65 ± 0.6*
1.85 ± 0.7
1.95 ± 0.7*
1.63 ± 0.6
1.66 ± 0.6
Kg (%·min−1)
Values shown as mean ± SD.
Units are taken from the MINMOD program. To convert value to SI units (10−4 min−1 [pmol/mL]−1), multiply by 0.167.
Di is calculated as Si generated from the MINMOD program (10−4 min−1 [μU/mL]−1) multiplied by AIRg (pmol·L−1 × 10 min).
*P < 0.05 for difference between baseline and posttraining mean values.
**P < 0.05 for difference in mean training response value between ethnic groups.
Si, insulin sensitivity index; AIRg, acute insulin response to glucose; Sg, glucose effectiveness; Di, disposition index; Kg, glucose disappearance rate
Adapted from Boule et al. (74) and unpublished data.

a

b
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response of glucose and insulin metabolism to training. On average, training led to beneficial changes in fasting insulin
levels, insulin sensitivity, and other glucose-insulin–related
traits derived from an IVGTT. Fasting glucose and insulin
measurements made 24 and 72 h after training indicate that,
on average, the favorable changes are greatly attenuated 3 d after the last exercise session. A more beneficial response pattern was observed among participants who had the least favorable glucose-insulin profile at baseline.

TRAINING, LIPID, LIPOPROTEINS, AND
LIPASES
Plasma lipid and lipoprotein levels were assayed from blood
samples collected 2 d apart in the morning after a 12-h fast at
baseline and, for most variables, 24 and 72 h after the last
training session. Concentration values were adjusted for potential plasma volume changes resulting from the training program based on plasma total protein concentration difference
between baseline and posttraining measurements. Plasma TC
and TG levels were determined, and the following lipoprotein
fractions were assayed by enzymatic methods: VLDL, HDL,
and LDL. ApoB and ApoA-I concentrations were measured,
and those of LDL-C, LDL-TG, and VLDL-ApoB were calculated. LPL and HL activities were measured in plasma obtained from 12-h fasted subjects, 10 min after intravenous injection of heparin (60 IU·kg−1 of body mass). The procedures
and assays used have been described in several publications
(18,82–85). Reproducibility of assays and the day-to-day variation in plasma levels have been reported in detail (18). Briefly,
the day-to-day variation in lipid and lipoprotein fractions was
estimated to be small, with intraclass coefficients >0.87 for repeated measurements in 379 participants for all traits except
HDL3-C (0.79). Similar levels of stability were observed based
on the assays performed on three samples obtained within 3 wk
in 60 subjects. Again, HDL3-C had the lowest coefficient of
0.71. CV values were 5% to 8% for all traits except TG (about
20%) and VLDL-C (about 30%). However, when the assays
were repeated on split samples from the same blood draw, the
intraclass coefficients were >0.93, with CV values <5%, except
for HDL2-C (10%). Plasma post-HL and LPL were also reliably
measured with split-sample repeatability coefficients >0.95.
Baseline Observations
The baseline plasma lipid, lipoprotein, and lipase activity profiles were compared between men and women and Blacks and
Whites and associated with cardiometabolic risk factors. Sex
differences were examined in a series of publications in Whites
(18,82,86), whereas ethnic and sex differences were examined
in two other articles (29,83). In general, men had less favorable
profiles than women (18,83,86) and Blacks more favorable
profiles than Whites (83) (Table 9). The ethnic differences in
plasma HL and LPL activities are concordant with results from
previous studies (88–90). The differences in plasma lipid profile
between men and women were largely explained by differences
in visceral adiposity and plasma LPL activity, whereas ethnicity
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significant. Similarly, there was no difference in the Si response between 272 premenopausal and 40 postmenopausal
women (74). No difference between Blacks and Whites was
found for the AIRg response to training. At baseline, the
IVGTT area under the glucose curve below fasting levels
was inversely correlated with changes in Kg (r = −0.30,
P < 0.001), suggesting that those who had the lowest glucose
at the end of the IVGTT had smaller improvements in glucose
tolerance. Changes in AIRg were weakly but positively associated (r = 0.09–0.13, P < 0.05), whereas changes in Si were not
associated with changes in body mass, waist circumference,
cardiorespiratory fitness, and plasma LDL-C, HDL cholesterol (HDL-C), or TG. These findings suggest that participants
who had more weight loss had a greater reduction in insulin
secretion, despite not having larger changes in insulin sensitivity (74).
After the 20-wk training program, fasting plasma insulin
and glucose were measured 1 and 3 d after the last exercise
bout (74). Fasting glucose in 547 participants slightly increased
between 24 and 72 h after the last exercise bout, a response that
was larger in Blacks than in Whites. Fasting insulin was decreased by 8% 24 h after the last exercise bout, which was comparable to the mean 10% increase in Si estimated from IVGTT.
Moreover, fasting insulin returned to baseline levels after 72 h.
This finding is consistent with those of previous studies, suggesting that improvements in insulin sensitivity and glucose tolerance were short-lived and became undetectable 60–72 h after
the last exercise session (76–78).
Familial aggregation of IVGTT-derived traits. Significant familial resemblance and heritability coefficients were
observed for the baseline levels of the IVGTT-derived variables
in both Blacks and Whites (79). After adjustment for age, sex,
and BMI, the heritability estimates in Blacks and Whites, respectively, were 48% and 25% for Kg, 44% and 46% for AIRg,
38% and 44% for Si, and 32% and 24% for Di. Interestingly,
Blacks had significantly higher heritability for overall glucose
tolerance than Whites, but there was no ethnic difference in heritability estimates for insulin sensitivity or insulin secretion. No
sex or generation differences were found in the familial correlations for any of the MINMOD traits (79). In the FUSION Study
(a cohort of offspring and spouses of adults with type 2 diabetes), the reported heritability estimates for Di (23%) and AIRg
(35%) were comparable to those from HERITAGE, whereas
the heritability estimates for Si (28%), Sg (18%), and AIRg
(35%) were somewhat lower in FUSION (80).
Changes in fasting insulin, Si, and Sg were characterized by
significant familial aggregation in their response patterns. Specifically, familial aggregation analyses based on general linear
models with adjusted data in MERLIN (81) showed that heritability estimates reached 8% for fasting insulin, 14% for Sg,
and 16% for Si responses to exercise training (unpublished data).
Changes induced by the exercise program in AIRg were not
characterized by significant familial resemblance.
In summary, the large sample of participants in a wellcontrolled exercise regimen in HERITAGE provided a unique
experimental context to study individual variations in the

TABLE 9. Plasma lipids, lipoproteins, and postheparin lipases in response to the HERITAGE exercise program by sex and ethnicity.
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Total Participants (n = 675)

Women (n = 376)

Men (n = 299)

Blacks (n = 250)

Whites (n = 481)

Variables

Before

After

Before

After

Before

After

Before

After

Before

After

Total Ca
TGa
LDL-Ca
VLDL-Ca
VLDL-TGa
HDL-Ca
HDL2-Ca
HDL3-Ca
TC/HDL-Ca
ApoA-1a
ApoBa
LDL-ApoBa
LPLb
HLb
HL·L−1PLb

171.0 ± 36.1
110.1 ± 63.2
114.4 ± 31.5
15.5 ± 12.6
69.5 ± 56.6
41.1 ± 10.6
13.9 ± 7.6
27.2 ± 5.2
4.4 ± 1.3
117.5 ± 16.7
84.4 ± 23.7
76.7 ± 21.4
61.3 ± 32.2
190.0 ± 74.0
5.3 ± 8.8

172.5 ± 35.8*
110.2 ± 67.2*
114.6 ± 30.8
15.4 ± 12.9
65.8 ± 56.0*
42.2 ± 11.0*
14.7 ± 8.0*
27.5 ± 5.0*
4.3 ± 1.4*
119.8 ± 16.1*
85.1 ± 23.6
77.5 ± 21.4*
68.2 ± 29.0*
179.4 ± 71.4*
3.6 ± 3.4*

168.0 ± 33.6
95.9 ± 48.7
115.5 ± 29.4
12.2 ± 8.2
53.5 ± 39.0
44.3 ± 10.2
16.4 ± 7.6
28.1 ± 5.5
4.0 ± 1.1
119.7 ± 17.1
80.4 ± 21.8
73.8 ± 20.1
67.4 ± 33.7
158.2 ± 63.9
3.5 ± 3.9

169.0 ± 33.4
95.3 ± 52.3
111.1 ± 28.7
12.1 ± 9.3
52.2 ± 43.0
45.7 ± 10.7*
17.9 ± 8.0*
27.8 ± 4.9
3.9 ± 1.1*
121.8 ± 16.8*
81.2 ± 21.8
74.3 ± 19.7
72.2 ± 31.1*
150.6 ± 62.5*
2.8 ± 2.5*

174.7 ± 39.9
127.4 ± 74.1
118.0 ± 33.7
19.5 ± 15.6
88.5 ± 67.5
37.1 ± 9.7
10.8 ± 6.3
26.3 ± 5.0
5.0 ± 1.6
114.3 ± 15.8
88.5 ± 25.2
79.8 ± 22.8
54.2 ± 28.8
228.2 ± 68.1
7.5 ± 12.0

173.9 ± 39.4**
121.5 ± 70.9*,**
117.1 ± 34.0
18.4 ± 14.4
82.0 ± 64.8**
38.2 ± 10.2*
11.5 ± 6.7*,**
26.7 ± 5.6*
4.8 ± 1.5*,**
117.0 ± 15.2*
88.1 ± 25.8**
79.7 ± 23.5
63.5 ± 25.4*,**
213.4 ± 66.2*,**
4.5 ± 4.1*,**

165.9 ± 33.6
92.5 ± 55.0
111.2 ± 29.4
12.0 ± 11.1
47.8 ± 40.3
42.3 ± 12.3
14.3 ± 9.0
28.0 ± 5.7
4.2 ± 1.4
115.5 ± 16.9
80.9 ± 22.5
74.6 ± 20.7
71.8 ± 34.2
152.8 ± 65.1
3.1 ± 3.3

167.5 ± 35.7
90.3 ± 58.5
111.8 ± 29.6
11.6 ± 10.9
43.4 ± 37.7*
43.4 ± 12.9*
15.9 ± 9.7*
27.6 ± 5.3
4.1 ± 1.4*
116.8 ± 16.0
81.8 ± 22.7
75.4 ± 21.1
76.5 ± 29.1*
143.4 ± 63.9*
2.3 ± 1.7*

174.3 ± 36.9
122.1 ± 69.1
116.2 ± 31.8
17.6 ± 13.2
78.7 ± 59.0
40.3 ± 9.9
13.5 ± 6.9
26.8 ± 5.1
4.6 ± 1.5
118.2 ± 17.0
86.3 ± 24.1
78.0 ± 21.6
56.6 ± 30.1
208.9 ± 70.7
6.4 ± 10.2

175.6 ± 36.1
120.4 ± 69.9
116.2 ± 31.3
17.2 ± 13.2
76.2 ± 59.3
42.0 ± 10.5*
14.4 ± 7.5*,***
27.6 ± 5.0*,***
4.4 ± 1.4*
121.9 ± 16.4*,***
86.8 ± 23.8
78.5 ± 21.5
64.3 ± 28.1*
196.5 ± 68.4*
4.2 ± 3.9*,***

To convert mg·dL−1 to mmol·L−1, divide cholesterol values by 38.7 and TG by 88.54.
a
mg·dL−1.
b
nmol·mL−1·min−1.
*P < 0.05 for difference between baseline and posttraining mean values.
**P < 0.05 for difference in mean training response value between sex groups.
***P < 0.05 for difference in mean training response value between ethnic groups.
Adapted from Leon et al. (84), Leon et al. (87), and unpublished data.

had only a minor contribution (29,83). Total body adiposity
accounted for 26% to 36% of the variance in baseline blood
lipids (29). Higher LPL activity was associated with a more favorable lipid–lipoprotein profile, whereas higher HL activity
was associated with an unfavorable profile in both men and
women (86). Fasting insulin was the only significant predictor
of LPL activity in men (negative association), whereas menstrual status and fasting insulin (negative associations) and
plasma sex hormone–binding globulin (SHBG) levels (positive association) were all independent predictors of LPL activity in women (86).
The distribution of the apolipoprotein composition of HDL,
specifically the concentration of HDL containing apolipoprotein
A-I only (LpAI) versus HDL with both apoA-I and apoA-II
(LpAI/AII), was examined (82). Women had higher LpAI and
lower LpAI/AII levels than men. As expected, LpAI was correlated with HDL2-C, whereas LpAI/AII was more closely associated with HDL3-C levels in both sexes. In both sexes, higher
LpAI levels were associated with higher HDL-C and apoA-I
and lower TC/HDL-C ratio, whereas LpAI/AII was positively
correlated with TC, apoA-I, apoB, and insulin. LpAI levels were
negatively correlated with body FM, waist circumference, and
fasting levels of TG, apoB, and insulin in women only.
Familial Aggregation Studies at Baseline
Familial aggregation of baseline plasma lipid, lipoprotein,
and lipase traits was assessed in 437 sedentary, White adults
(171 parents, 266 offspring) from 86 families (85). Significant
familial aggregation was observed for all age-adjusted phenotypes (TC, HDL-C, LDL-C, TG, LPL, HL), with heritability
estimates of 62%, 83%, and 50% for TC, HDL-C, and LDL-C,
respectively. For plasma TG levels and HL activity, the heritability estimates were 55% and 40%, respectively, but significant spouse correlations were found, suggesting common familial environment contributed to familial resemblance in
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addition to genetic factors. For plasma LPL activity, sex differences were found, with higher heritability in female pairs
(76%) than in male pairs (30%) and opposite-sex pairs (44%).
Effects of the Training Program
The training responses of the lipid, lipoprotein, and lipase
profile are summarized in Table 9. A 3.6% increase in plasma
HDL-C was found in the total sample, mostly due to an increase
in HDL2-C, with an associated increase of apoA-I (84). Significant reductions in plasma TG and VLDL-TG levels were observed in the 24-h samples only, reflecting a response to the last
bout of exercise and not a training effect, per se. No changes
were observed in TC, LDL-C, VLDL-C, and apoB. The findings for HDL-C are concordant with those from a review of
100 training studies that found changes in HDL-C ranged from
4% to 22% (91), as well as from a meta-analysis that found a
modest net increase in HDL-C of 2.53 mg·dL−1 across 25 randomized clinical trials (92).
Effects of training on the lipoprotein subclass profile.
The investigation of the effects of training on lipids–lipoproteins
was expanded by examining changes in the lipoprotein subclass
profile measured by NMR (LabCorp, Morrisville, NC) (93).
Overall, the concentration of large HDL (HDL-P) and large
LDL (LDL-P) particles increased with training, while the concentration of small LDL-P and total, large, medium, and small
VLDL-P and mean VLDL-P size decreased with training. These
changes mirrored those found in a previous HERITAGE report,
where the increase in HDL-C was mostly driven by increases
in the larger HDL2-C subclass and not the smaller HDL3-C
subclass (84). These results were expanded in a meta-analysis
of 10 exercise interventions from six studies (including HERITAGE), which found significant changes in the following lipoprotein subclasses (independent of age, sex, ethnicity, baseline
BMI, and baseline trait value): decreases in the concentration
of large VLDL-P, small LDL-P, and medium HDL-P and mean
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differences in the HDL-C response were noted by age, sex,
or ethnicity (84,87). However, Blacks experienced greater increases in HDL2-C. Relative to apoA-I, there were greater increases in women than in men, in Blacks than in Whites, and
in offspring than in parents (84). At the univariate level, absolute change in FM was correlated with change in HDL-C
(r = −0.23), HDL2-C (r = −0.17), and TC/HDL-C (r = 0.24)
in men and with change in LDL-C (r = 0.22), TC (r = 0.19),
and TC/HDL-C (r = 0.15) in women (95). Ethnicity was a significant predictor of changes in TG in both sexes.
Significant reductions in plasma HL activity and increases
of LPL activity were observed in all sex and ethnic subgroups,
except that the increase in LPL activity was not significant in
Black men (97). Change in LPL activity was correlated with
change in AVF (r = −0.17 for Whites and −0.26 for Blacks).
In Whites, change in LPL activity was correlated with change
in waist circumference (r = −0.18) and subcutaneous fat
(r = −0.23), as well as change in TG (r = −0.20) and HDL-C
and HDL2-C (r = 0.21 and 0.23). The finding of increased
LPL activity associated with a decrease in TG reflects the hypothesis of an increased ability to clear TG-rich lipoproteins
with regular exercise.
Variability in plasma lipid and lipoprotein responses
to training. Although the mean increase in HDL-C was 3.6%,
there was wide variability in responsiveness to training, ranging
from a mean decrease of 9.3% in quartile 1 (mean reduction of
0.11 mmol·L−1) to a mean increase of 18% in quartile 4 (mean
increase of 0.18 mmol·L−1) of the HDL-C response distribution
(87). Parallel changes in HDL2-C and HDL3-C, apoA-I levels,
and LPL activity were seen across quartiles of HDL-C response.
A multivariate regression analysis that included baseline variables accounted for 15.5% of the variability in HDL-C response to training, with percent change in TG accounting for
8.8%, baseline HDL-C for 1.5%, baseline LPL activity for
1.2%, and baseline insulin for 1.0% (87).
The variability in lipid and lipoprotein responses to training
was also highlighted in the previously mentioned study

FIGURE 5—Distribution of the response of HDL-C (left panel ) and TG (right panel ) to the HERITAGE exercise program with potential adverse
responders highlighted in red, and the most favorable responders shown in green, both defined as plus or minus 2 × the technical error for each trait.
To convert mmol·L−1 of HDL-C to mg·dL−1, divide by 0.02586. To convert mmol·L−1 of TG to mg·dL−1, divide by 0.01129. Adapted with permission
from Bouchard et al. (75).
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VLDL-P size, with significant increases in the concentration of
large LDL-P and large HDL-P and mean LDL-P size (93).
These results highlight that despite several studies showing
no changes in some of the traditional measures of lipids–
lipoproteins (e.g., TG and LDL-C did not change in HERITAGE), NMR subclass profiling revealed significant and favorable changes in several lipoprotein subclasses in response
to training.
Association of plasma lipid, lipoprotein, and lipase
activity responses to training, with concomitant changes
in cardiometabolic risk factors. A study categorized men
into four groups based on baseline TG (low/high) and HDL-C
(low/high) concentrations and found that endurance training
may be particularly beneficial in men with low HDL-C, elevated TG, and abdominal obesity (94). Greater fat loss, characterized by loss of FM, AVF, and abdominal subcutaneous
fat, was associated with a better lipid response to training,
characterized by an increase in HDL-C and decreases in TG,
LDL-C, TC, and TC/HDL-C (29). In fact, a composite variate
of change in body fat accounted for 21% of the variance in a
composite variate of change in blood lipids in Blacks and 7–
10% in Whites. Change in AVF was not as strongly associated
with changes in lipids in Blacks as in Whites. Changes in lipid
traits were not related to concomitant changes in V̇O2max (95).
Weak but significant correlations were also found between
change in submaximal HR at 50 W with change in HDL2-C
(r = −0.17; significant in men, women, Whites) and LDL-C
(r = 0.09, significant in men and Blacks) (40).
Although the predictors of lipoprotein subclass trait responses
to training are largely unknown, a recent study (96) found that
baseline levels of a circulating biomarker of liver fat called
dimethylguanidino valeric acid (DMGV) were positively associated with changes in small HDL-P (β = 0.14) and inversely associated with changes in medium and total HDL-P (β = −0.15 and
−0.19, respectively) and apoA-I (β = −0.14).
Ethnic and sex differences in plasma lipid, lipoprotein, and lipase activity responses to training. No
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examining the prevalence of potentially unfavorable responses
to training across six studies (75). Adverse responses were defined as a decrease in HDL-C ≤0.12 mmol·L−1 or an increase of
TG ≥0.42 mmol·L−1. Figure 5 depicts the changes in HDL-C
and TG for all HERITAGE subjects, with the individual values
highlighted in red representing those with unfavorable responses. The prevalence of adverse response for change in
HDL-C was 6% in Whites and 8% in Blacks and 8% in both
Blacks and Whites for change in TG. Across all six studies
(n = 1687), the prevalence of adverse response was 13.3% for
HDL-C and 10.3% for TG. The prevalence of unfavorable responses seemed to be similar across variable doses of training.

the process was adequately controlled through calculation of
recovery rates. Moreover, two blood samples were obtained
at least 24 h apart at baseline, as well as two samples after training, one 24 and the other 72 h after the last exercise session. A
large panel of steroid hormones or their derivatives were assayed
(see Ukkola et al. (101) and He et al. (28)), including commonly
measured hormones such as TESTO, E2, PROG, ALDO, and
CORT. Steroid precursors such as DELTA4, PREGE, or the free,
fatty-acid ester, and sulfated moieties of dehydroepiandrosterone
(DHEA, DHEAE, DHEAS) were also examined, in addition to
steroid metabolites such as DHT, ADTG, and androstenediol
glucuronide (DIOLG). Circulating levels of the peptide steroid
transporter SHBG were also examined.
Extensive quality control analyses were used to quantify the
reproducibility of the steroid assays and document the day-to-day
variability of hormone levels in the HERITAGE population.
Moreover, blood samples were obtained in the early follicular
phase of the menstrual cycle in premenopausal women before
and after training. In brief, the reliability of repeated assays
from split samples was highly significant, with intraclass coefficients generally >0.9 in 35 males and 25 females (28). Test–
retest on 2 d apart in the whole cohort yielded coefficients of
>0.8 in men and women, except for CORT (0.52) and E2 in
males (0.59). All assays performed three times over 3 wk
had intraclass coefficients of ≥0.70, except for ALDO in women
(0.40), CORT in men (0.55), and PREGE in men (0.69).
Baseline observations. The baseline levels of all steroids and their response to training for the sample of men by
ethnicity are displayed in Table 10. The steroid levels before
and after training are shown in Table 11 for premenopausal
women taking or not taking oral contraceptives, and for postmenopausal women with and without HRT.
Baseline levels of plasma steroids were examined in several
publications (101,102,104). As summarized by Ukkola and
colleagues (101), age was a predictor for most steroid hormones, with the strongest relationship observed for DHEAS
(r = −0.39), whereas BMI was also associated with the

Familial Aggregation Studies of Training Response
Familial aggregation was the strongest predictor of interindividual variation in plasma lipid responsiveness to training.
For example, there was 1.8 times more variance between families than within families for HDL-C changes (44). Familial
correlations for the training responses were significant for most
lipid–lipoprotein variables, with heritability estimates ranging
from 25% to 38% (98). Exceptions were for heritability levels
near 60% for changes in apoB in Blacks and HDL2-C in Whites
and a lack of heritability for change in LDL-C in Blacks. Heritability estimates ranged from 26% (Blacks) to 29% (Whites)
for change in HDL-C and from 29% (Whites) to 32% (Blacks)
for change in TG. In Whites, the heritability estimate for
training-induced changes in LPL activity was 15% (99).

TRAINING, STEROIDS, AND OTHER
HORMONES
Although mass spectrometry measurements are nowadays
considered the gold standard for the quantification of plasma
steroid levels (100), the assays used in HERITAGE were antibody based. However, the approach included prior extraction
of steroids as well as high-pressure liquid chromatography
separation before antibody measurements, and each step of

TABLE 10. Steroid hormone levels at baseline and in response to the HERITAGE exercise program in men.
Men (n = 267)

Blacks (n = 67)

Whites (n = 200)

Variables

Before

After

Before

After

Before

After

ADTG
ALDO
CORT
DELTA4
DHEA
DHEAE
DHEAS
DHT
DIOLG
E2
OHPROG
PREGE
PROG
SHBG
TESTO

156 ± 85
0.26 ± 0.1
375 ± 111
2.8 ± 1.4
15.6 ± 10.0
9.3 ± 5.7
5652 ± 3091
2.7 ± 1.2
28.5 ± 13.7
71.3 ± 44.1
5.5 ± 2.8
16.6 ± 9.5
1.66 ± 0.8
39.2 ± 16.5
15.0 ± 6.0

158 ± 91
0.28 ± 0.2
394 ± 122*
2.7 ± 1.3
14.5 ± 9.1*
8.7 ± 5.1
5593 ± 3032
2.7 ± 1.1
29.9 ± 20.8
72.3 ± 43.5
5.5 ± 2.7
15.3 ± 8.8*
1.63 ± 0.9
39.2 ± 16.2
15.1 ± 5.6

160 ± 70
0.2 ± 0.1
349 ± 99
2.7 ± 1.1
14.7 ± 6.6
10.1 ± 4.7
5469 ± 2586
3.2 ± 1.3
29.5 ± 12.6
79.3 ± 39.8
4.3 ± 2.2
18.8 ± 9.2
1.80 ± 0.8
37.6 ± 15.7
16.2 ± 6

157 ± 67
0.2 ± 0.1
364 ± 113
2.4 ± 1
12.9 ± 5.7
8.1 ± 3.6
5065 ± 2247
3.0 ± 1.3
30.8 ± 13.5
82.2 ± 50.8
4.5 ± 2.1
14.9 ± 6.8
1.70 ± 0.8
38.5 ± 15.4
16.2 ± 5.9

155 ± 89
0.3 ± 0.2***
383 ± 113***
2.8 ± 1.5
15.9 ± 10.9
9±6
5715 ± 3247
2.6 ± 1.2***
28.2 ± 14.1
68.6 ± 45.2
5.8 ± 2.9***
15.8 ± 9.6
1.60 ± 0.8
39.8 ± 16.7
14.7 ± 6

158 ± 98
0.3 ± 0.2
404 ± 123
2.9 ± 1.4**
15 ± 10
8.9 ± 5.5**
5770 ± 3238**
2.6 ± 1.0
29.6 ± 22.8
69.0 ± 40.3
5.9 ± 2.9
15.5 ± 9.4**
1.60 ± 0.9
39.4 ± 16.5
14.7 ± 5.5

Units are nmol·L−1, except for E2 (pmol·L−1).
*P < 0.05 for difference between baseline and posttraining mean values.
**P < 0.05 for difference in mean training response value between ethnic groups.
***P < 0.05 for differences between ethnic groups at baseline.
Adapted from Ukkola et al. (101), He et al. (102), He et al. (103), and unpublished data.
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TABLE 11. Steroid hormone levels at baseline and in response to the HERITAGE exercise program in women by menopause and hormonal drug status.
Premenopausal, No OC (n = 167)
Variables

Postmenopausal, No HRT (n = 24)

Postmenopausal, HRT (n = 22)

After

Before

After

Before

After

Before

After

101 ± 55
0.2 ± 0.2
358 ± 134
2.6 ± 1.5
14.8 ± 9.6
8.4 ± 5.4
4023 ± 2212
0.5 ± 0.2
15.6 ± 8.1
130 ± 106
2.3 ± 1.7
15.2 ± 9.0
1.6 ± 0.8
66.1 ± 27.0
1.3 ± 0.5

98 ± 55
0.2 ± 0.2
414 ± 174
2.6 ± 1.5
14.5 ± 10.2
7.5 ± 4.8*
3823 ± 2185*
0.6 ± 0.4
16.1 ± 9.1
137.1 ± 126
2.7 ± 3.4
14.5 ± 8.7
1.5 ± 0.8
68.4 ± 34.3
1.3 ± 0.5

82 ± 41
0.3 ± 0.2
662 ± 275
2.5 ± 1.6
16.3 ± 11.0
7.9 ± 5.5
4132 ± 2271
0.5 ± 0.3
12.5 ± 5.8
125 ± 221
2.1 ± 1.4
13.4 ± 9.4
1.4 ± 0.7
113.3 ± 58.2
1.4 ± 0.6

84 ± 43
0.3 ± 0.2
683 ± 305
2.8 ± 1.3
17.0 ± 9.7
8.2 ± 5.4
4087 ± 2186
0.5 ± 0.3
13.4 ± 7.2*
105 ± 127
2.1 ± 1.3
14.3 ± 10.7
1.4 ± 0.7
109 ± 55.2
1.4 ± 0.6

66 ± 37
0.2 ± 0.1
368 ± 129
1.5 ± 0.8
7.9 ± 4.8
5.6 ± 3.7
1882 ± 1019
0.5 ± 0.3
12.1 ± 6.5
45 ± 55
1.7 ± 0.9
11.2 ± 6.3
0.9 ± 0.6
65.9 ± 24.4
1.4 ± 1.2

68 ± 41
0.2 ± 0.1
401 ± 137
1.5 ± 0.8
8.5 ± 7.0
5.6 ± 3.5
1930 ± 1061
0.5 ± 0.2
11.8 ± 5.5
36 ± 51
1.6 ± 0.9
10.9 ± 7.3
0.8 ± 0.5
62.7 ± 25.6
1.1 ± 0.4

61 ± 45
0.2 ± 0.2
369 ± 129
1.3 ± 0.6
6.8 ± 4.0
3.8 ± 2.0
1677 ± 830
0.4 ± 0.1
9.4 ± 5.8
333 ± 389
1.2 ± 0.8
6.7 ± 3.0
0.7 ± 0.5
118.6 ± 61.8
1.1 ± 0.5

58 ± 42
0.2 ± 0.2
427 ± 165
1.3 ± 0.7
7.2 ± 5.5
4.5 ± 2.5
1709 ± 1002
0.4 ± 0.2
9.2 ± 5.8
325 ± 415
1.2 ± 0.8
7.3 ± 4.1
0.7 ± 0.4
113.2 ± 59.0
1.0 ± 0.5

Units for all variables are nmol·L−1, except E2 (pmol·L−1).
*P < 0.05 for difference between baseline and posttraining mean values.
OC, oral contraceptives.
Adapted from He et al. (28) and unpublished data.

variability of several measurements, including SHBG (r = 0.20)
and TESTO (r = 0.12). When age and BMI were taken into account, ethnicity still contributed significantly to variations in
CORT and DHT (for men and women) and in PROG for
women. However, ethnicity had a much lower influence on
plasma steroid levels than age and BMI. In addition, caloric
and nutrient intakes, and smoking influenced steroid hormone
variability, but their contributions were minor once age, BMI,
and ethnicity were taken into account (101).
The well-documented decline in androgen levels with age
observed in males (105,106) was also observed in men of HERITAGE. Interestingly, the concomitant age-related increase in
total body FM explained an important part of the variation in
steroid levels in men, particularly for TESTO levels (104).
These results are consistent with those from studies showing
an important contribution of adiposity indices to variations in
steroid hormone levels in men (107), women (108) and in
men and women of HERITAGE (102). In another HERITAGE
report, baseline sex hormone and SHBG levels were examined
in men and women with an emphasis on postheparin lipolytic
enzyme activities (86). Activities of LPL and HL are known
to be sensitive to androgens and estrogens, which likely explains part of the sex differences in blood lipids, particularly
for HDL-C (109). TESTO was found to be an independent predictor of HL activity (r = 0.13), consistent with the known effects of androgens in decreasing HDL-C levels. In women,
SHBG levels, which are regulated in part by androgens and estrogens, were correlated with HL activity (r = −0.39), independent of adiposity. This study showed that the sensitivity of lipase activities to sex hormones was confirmed in a large sample
of men and women (86).
At baseline, increasing V̇O2max was related to higher androgen levels (TESTO and DHT), as well as higher SHBG levels
after adjustment for age and ethnicity (28). In women, no significant hormonal variations were observed as a function of
V̇O2max, except for the free androgen index (TESTO/
SHBG × 100) which was lower across increasing baseline

THE HERITAGE FAMILY STUDY: A REVIEW

V̇O2max quartiles. However, the overall strength of the associations between baseline hormones and V̇O2max was relatively low.
Familial aggregation at baseline. Baseline hormone
and SHBG levels were examined as a function of familial aggregation (110–114). The factors examined in these analyses
were DHEA, DHEAE and DHEAS (111,113), SHBG (110,112),
and androgens and glucuronide conjugates (114). Regarding
DHEAS, Whites showed a heritability estimate of 58% at
baseline. Segregation analyses suggested a major Mendelian
locus affecting baseline DHEAS accounting for about half of
the trait variance (111). Ethnicity-related differences in familial aggregation patterns were also examined for DHEAS, and
a comparable level of heritability of 66% was found (113).
Baseline levels of SHBG differed by sex, with higher levels
in women, whereas SHBG levels were higher in fathers than in
sons (111). Familial aggregation analyses of SHBG levels are
consistent with the idea that multiple factors regulate the secretion of this hepatokine (115). A significant amount of the variance in SHBG was accounted for by TESTO, E2, age, BMI,
and insulin. Nevertheless, the heritability estimate was 64%,
independent of these factors. Analyses in Blacks revealed similar heritability levels (110).
CORT levels were significantly different between sex and
generation groups at baseline in Whites, with higher values
in females and offspring (116). In Blacks, lower baseline
CORT levels were found in mothers than in fathers and higher
levels in offspring and in daughters than in sons. The heritability of CORT was lower than for other steroids examined (116).
Interestingly, familial cross-trait correlations and bivariate segregation analyses generated consistent results, suggesting common
familial components underlying CORT and body fat covariation caused by common polygenic determinants (117). Such
genetic pleiotropy was not found for the association of SHBG
and adiposity indices (118). Evidence of genetic pleiotropy
between CORT levels and adiposity phenotypes agrees with
the well-known coregulation of adiposity, body fat distribution, and glucocorticoid homeostasis (119,120).
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ADTG
ALDO
CORT
DELTA4
DHEA
DHEAE
DHEAS
DHT
DIOLG
E2
OHPRG
PREGE
PROG
SHBG
TESTO

Premenopausal, OC (n = 88)

Before
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Finally, familial resemblance of circulating androgens and
androgen metabolites at baseline was also examined (114).
There were sex and generation differences at baseline, with
parents having lower levels than offspring and males higher
levels than females in both generations and ethnicities. This
analysis again revealed high heritability estimates for most of
the androgens and metabolites examined. For example, heritability levels in Whites reached 69% and 87% for TESTO and
DHT, respectively, which were similar in Blacks (70% and
73%, respectively). The androgen metabolite DIOLG has been
the focus of many studies in the field of obesity and body fat
distribution (121,122). The relatively high heritability estimates obtained for this steroid (74% and 62% in Whites and
Blacks, respectively) need to be considered in light of results
from more recent twin studies indicating that differences in circulating DHT between lean and heavier co-twins are related to
increased expression of androgen-metabolizing enzyme aldoketoreductase 1C2 in adipose tissue (123,124). Genomewide linkage scans were performed in HERITAGE to identify
loci influencing the various moieties of DHEA (125), as well
as other steroids and SHBG (126). The results from these studies are of particular interest in the context of the growing body
of evidence supporting the existence of an elaborate set of
steroid-converting enzymes in human adipose tissues (122).
Effects of the exercise program. The training program
had only marginal effects on fasting plasma levels of steroid
hormones and SHBG, as evidenced by data in Tables 10 and
11. In males, only CORT had a significant increase with training, whereas DHEA and PREGE showed a decrease (Table 10).
In premenopausal women not taking oral contraceptives, DHEAS
decreased significantly with training, whereas DIOLG increased
in those taking oral contraceptives (Table 11). No significant
change in any steroid was observed in postmenopausal women
with or without HRT, a finding that may have been impacted by
the relatively small sample size of women in each group.
The impact of baseline steroid levels on changes in cardiorespiratory fitness and body composition in response to training was examined in HERITAGE (28,102,103). Sex hormones
were not related to the change in V̇O2max, suggesting that high
baseline endogenous androgen levels do not predict higher responses to endurance exercise training in previously sedentary
adults (28). No association was detected between baseline

steroid hormone levels and changes in adiposity traits (102) or
the improvements in resting and exercise BP (103). In another
report, the impact of menopausal status and HRT on exercise
hemodynamics during exercise was examined (66). Menopausal
status was found to influence training adaptation of SBP, as menopausal women improved more. Age was a major covariate of
variability in hemodynamic parameters (66). Postmenopausal
women showed less improvement in SBP during submaximal
exercise with the training program when taking HRT (66).
Among other findings, no sex, generation, or ethnic differences
were observed for mean change in SHBG with training (110).
In Blacks, no differences between sexes and generations were
observed for CORT training response.
Familial aggregation of responses to the training
program. An analysis based on White families showed that
changes in plasma DHEAS was characterized by a nonsignificant heritability level of 30% (113). The training response of
SHBG level was also characterized by very low heritability estimates (110,112). Segregation analyses based on the White
families provided evidence for a major locus effect influencing
the CORT response to training; this was not detected in
Blacks, perhaps because of the smaller sample size (116).

TRAINING AND OXIDATIVE STRESS
Excess reactive oxygen species production is thought to contribute to the development of atherosclerosis and cardiovascular
disease. Oxidative alterations of LDL particles are thought to
play a critical role in atherosclerosis and in inflammatory processes. Hemolysis induced by reactive oxygen species is an indicator of the overall antioxidant capacity. An ancillary study
investigated these areas on a HERITAGE subsample at baseline
and in response to training, with an emphasis on total homocysteine (tHcy), LDL oxidation, erythrocyte glutathione peroxidase activity (GSH-Px), retinol, and erythrocyte resistance
to hemolysis (127).
Baseline characteristics. Significant sex and ethnic differences in tHcy were observed before training in the full cohort
(n = 816). tHcy was highest in Black men (11.0 ± 7.2 μmol·L−1),
followed by White men (9.4 ± 3.7 μmol·L−1), Black women
(8.5 ± 4.2 μmol·L−1), and White women (7.7 ± 2.7 μmol·L−1)
(128). Although results from cross-sectional studies corroborate

TABLE 12. Baseline, training response, and familial aggregation of measures of oxidative stress in Whites of the HERITAGE Family Study.
Baseline

Training Response

Familial Aggregation
Oxidative Stress Trait
−1

Plasma glutathione (μmol·L )
Erythrocyte antioxidant enzyme GSH-Px (U·g−1 hemoglobin erythrocyte)
Resistance to hemolysis
(C50-AAPH; mmol·L−1)
LDL oxidation lag phase (min)
LDL oxidation propagation rate (nmol·mg−1 LDL·min−1)
Plasma TBARS (nmol MDA·mL−1)

Familial Aggregation

n

Mean (SD)

F

H2

Mean (SD)

Training Effect
(P Value)

142
109
106

4.5 (1.5)
57.2 (15.4)
75.9 (14.0)

2.56
6.09
3.06

0.44
1.00
0.36

0.04 (1.8)
−0.5
3.6 (16.1)

NS
NS
0.02

3.20
NS
2.08

0.46
0.002
0.35

71
71
138

58.4 (23.3)
8.9 (2.6)
1.9 (0.7)

3.12
2.02
3.19

0.38
0.31
0.43

6.2 (38.9)
0.3 (4.0)
−0.04 (0.9)

NS
NS
NS

2.97
2.12
3.15

0.84
0.44
0.51

F

H2

Mean values and training response P values have not been adjusted for any covariates. F ratio compares the between-family with the within-family variances and thus provides an estimate of
familial resemblance. H 2 is the heritability coefficient.
NS, not significant (P > 0.05).
Adapted with permission from Blache et al. (127) and unpublished data.

S18

Official Journal of the American College of Sports Medicine

http://www.acsm-msse.org

THE HERITAGE FAMILY STUDY: A REVIEW

To conclude, subjects with elevated tHcy at baseline had
significantly reduced tHcy levels with training. Although the
clinical utility of tHcy for assessing CHD risk has been called
into question (132), some evidence suggests that the observed
reductions in tHcy may be enough to reduce CHD risk in those
with hyperhomocysteinemia (133). The other beneficial effect
of training was increased resistance to hemolysis of erythrocytes in women, which was significantly attenuated by smoking.
Recently, distinct hematological patterns were found in smokers,
and the differences were associated with greater risk of CHD in
smokers (134). Similar results were reported in a cohort of over
100,000 Danish individuals where smoking was causally associated with increased blood leukocytes, neutrophils, lymphocytes,
and monocytes. In addition, they suggest that smoking results
in decreased erythrocyte life span due to increased hemolysis
(135). Thus, cessation of smoking is likely necessary to improve
erythrocyte fragility through training.
Overall, training only modestly improved markers of oxidative stress. These results were somewhat surprising, as regular
exercise has been previously shown to decrease systemic oxidative stress and attenuate oxidative damage throughout the body
(136,137). A potential reason for the apparent disagreement
between the HERITAGE findings and those from other studies could be use of animal models in many studies examining
training and oxidative stress that may not be generalizable to
humans. Furthermore, training may reduce oxidative stress
in older individuals only (136); thus, the HERITAGE cohort
with its age inclusion limited to 65 yr may not represent the
ideal target population for exercise interventions aimed at improving antioxidant defenses. Further research in diverse populations is needed to elucidate the impact of training on markers
of oxidative stress.

EXERCISE AND SKELETAL MUSCLE BIOLOGY
Biopsies of the vastus lateralis muscle were obtained before
and after training in a subset of 78 subjects from 19 White families (138). This subsample had a mean age of 33 yr and a
mean BMI of 25 kg·m−2. Fiber type distribution, fiber areas,
capillarity, and enzyme activities were assayed as described
previously (139–141). This HERITAGE ancillary study was
led by Dr. Jean-Aimé Simoneau, who passed away shortly after the completion of data collection.
Baseline observations. Means and SDs for the proportion of type 1, 2A, and 2B fibers were close to the values previously reported from the same laboratory in samples of 203
adult females and 215 adult males ranging in age from 16 to
33 yr (142). The proportions of type 1 fibers were 43.2%
(SD, 11.8) and 20.0% for type 2B (138). Mean fiber type areas
were ~20% larger in the HERITAGE subsample than in the
10-yr younger cohort of 418 adults reported by Simoneau
and Bouchard (142). Muscle enzyme activities were characterized by considerable heterogeneity, with CV values of 20% to
25% for creatine kinase (CK), phosphorylase (PHOS), hexokinase (HK), phosphofructokinase (PFK), glyceraldehyde phosphate dehydrogenase (GAPDH), carnitine palmitoyl transferase
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the finding of greater tHcy in males, evidence for ethnic differences is mixed, with some studies reporting White males having the highest tHcy levels (129) and others reporting no significant differences by ethnicity (130). Sex differences did
not persist in measures of oxidative stress other than tHcy.
Other measures of oxidative stress were examined in a subset of 146 subjects from 28 two-generation, White, nuclear
families from the Quebec clinical center (Table 12). A significant proportion (31.6%) of the variation in LDL oxidation lag
time was accounted for by LDL-C, plasma α-tocopherol, serum uric acid, and plasma phospholipid oleic acid (127). Baseline plasma α-tocopherol, β-carotene, and retinol levels, as
well as GSH-Px, were all significantly higher in parents than
in children of either sex, whereas plasma glutathione was
higher in children than in parents (127). The relationship between oxidative stress and aging is well established, particularly mitochondria oxidative stress commonly considered as
one of the drivers of the aging processes (131). Thus, the observed differences in baseline markers of oxidative stress
across generations were expected and support an association
between aging and elevated oxidative stress.
Effects of the training program. tHcy did not change in
response to training. However, a subgroup analysis revealed
differential responses by baseline tHcy levels and ethnicity.
Exercise training resulted in a significant reduction of tHcy
(−3.5 ± 7.0 μmol·L−1) in subjects with elevated baseline tHcy
(≥15 μmol·L−1), whereas a significant increase (+0.3 ± 1.5 μmol·L−1)
was observed in subjects with normal baseline levels of tHcy
(<15 μmol·L−1) (128). Furthermore, training resulted in a
nominal decrease in tHcy in Black males and a nominal increase in White males (P = 0.04 between Blacks and Whites)
(128). In the ancillary study of Whites from the Quebec center, the only measure of oxidative stress that significantly
changed with training was erythrocyte resistance to hemolysis, with no change in the other markers (Table 12). Interestingly, smoking status was a significant modifier of the beneficial erythrocyte response to training. Instead of beneficial
effects of training, erythrocytes of smokers had a greater susceptibility to hemolysis after training (127). In sex-specific
analyses, the percent increase in total glutathione was significant in both men and women, whereas erythrocyte resistance
to hemolysis and plasma α-tocopherol was improved with training in women only (127).
Familial aggregation profile. There was significant familial aggregation of measures of oxidative stress at baseline
and in response to training (Table 12). Specifically, LDL oxidation lag time and propagation rate, erythrocyte resistance to
hemolysis, plasma thiobarbituric acid–reacting substance
(TBARS), and plasma glutathione all exhibited significant familial aggregation at baseline and after training. Erythrocyte
GSH-Px showed significant familial aggregation at baseline,
but not in response to training (127). The baseline traits showed
two to six times more variance between families than within
families with maximal heritability estimates ranging from 31%
to >90%, whereas maximal heritability estimates for training
response traits ranged from 35% to 84%.

TABLE 13. Effects of the endurance exercise program on vastus lateralis muscle fiber type, capillarity per fiber, and enzyme activities, and the familial aggregation of the training response.
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Training Effect

Familial Aggregation of Training Response

Muscle Trait

Pretraining

Training Response

P

F Ratio

P

% type 1
% type 2 A
% type 2B
Type 1 caps
Type 2A caps
Type 2B caps
CK
PHOS
HK
PFK
GAPDH
LPL
CPT
HADH
CS
COX

43.2 (11.8)
36.8 (8.9)
20.0 (11.2)
4.58 (0.81)
4.40 (1.00)
3.47 (1.00)
389 (68)
19.9 (4.9)
2.5 (0.5)
57.3 (13.9)
422 (94)
0.87 (0.27)
0.12 (0.02)
16.2 (3.0)
11.5 (2.1)
7.0 (1.7)

3.5 (9.4)
1.8 (9.9)
−5.4 (10.3)
0.76 (0.72)
0.63 (0.77)
0.55 (0.68)
27 (69)
1.6 (3.3)
0.4 (0.5)
4.9 (10.6)
7 (66)
−0.01 (0.28)
0.05 (0.02)
4.6 (3.0)
5.7 (2.5)
2.9 (2.5)

0.003
NS
0.0001
0.0001
0.0001
0.0001
0.0009
0.0001
0.0001
0.0002
NS
NS
0.0001
0.0001
0.0001
0.0001

0.62
1.81
1.13
1.65
1.75
0.99
3.97
2.14
4.01
1.85
2.39
1.35
2.47
2.13
2.73
2.07

NS
0.057
NS
0.09
0.07
NS
0.0001
0.017
0.0001
0.043
0.007
NS
0.006
0.017
0.002
0.021

Mean and (SD). F ratio of the between- to within-family variance components. Number of subjects ranged from 60 to 78 depending on the muscle trait. The Vmax of enzymes was expressed in
micromoles of substrate per gram of wet weight tissue per minute. Total muscle LPL was expressed as nanomicromoles of FFA transformed per gram of wet weight tissue per minute.
NS, not significant (P > 0.05); caps, number of capillaries per fiber; CK, creatine kinase; PHOS, phosphorylase; HK, hexokinase; PFK, phosphofructokinase; GAPDH, glyceraldehyde phosphate
dehydrogenase; LPL, lipoprotein lipase; CPT, carnitine palmitoyl transferase; HADH, 3-beta-hydroxyacyl CoA dehydrogenase; CS, citrate synthase; COX, cytochrome c oxidase.
Modified from data reported in Rico-Sanz et al. (138) and Rankinen et al. (143).

(CPT), 3-beta-hydroxyacyl CoA dehydrogenase (HADH), citrate
synthase (CS), and cytochrome c oxidase (COX) (143). Variability of the enzyme activities in the HERITAGE sample was
slightly lower than in the larger cohort of younger sedentary adults
(142). The more glycolytic type 2B fibers were characterized by
a lower capillary density than in muscle type 1 and 2A fibers.
Effects of the training program. As depicted in Table 13,
there were increases in the proportion of type 1 fibers (about 3%)
and decreases in type 2B fibers with no change in type 2A (138).
The significance of these changes is unclear, as they are well
within the confidence intervals of the fiber type assessment procedures (139). There were no changes in the surface areas of
the various fiber types. The number of capillaries surrounding
each fiber type increased with training, but the ratio of capillaries
to fiber type areas decreased for all fiber types. Muscle enzyme
activities were substantially and significantly increased after
training, except for GAPDH and LPL.
Familial aggregation profile. The muscle biopsy data
came from 19 nuclear families. Considering that there is a dearth
of data on the genetic epidemiology of skeletal muscle phenotypes, HERITAGE offered an opportunity to test whether there
was familial aggregation in the sedentary state and in response
to training (138). There was no consistent evidence for familial

aggregation of fiber type distribution or fiber type areas in
the sedentary state, with the exception of type 1 fibers. However, significant familial resemblance was observed for the
number of capillaries and the number of capillaries per surface
area around fiber types 1 and 2A. No evidence of family lines
was detected in the observed variability of fiber type distributions, surface areas, and capillarity in response to training, although there were trends of familial aggregation for number of
capillaries surrounding types 1 and 2A fibers. In contrast, strong
familial aggregations for muscle enzyme activities (CK, PHOS,
HK, PFK, CPT, HADH, CS, and COX) were observed at baseline (except GAPDH and LPL) and in response to the exercise
program, with the exception of total muscle LPL (143). Studies
with much larger sample sizes would be needed to provide more
definitive quantification of the variability within and between
families, along with relevant heritability estimates.

TRAINING AND RESTING METABOLIC RATE
Research is equivocal on the effects of endurance training
on RMR (144–152). Seventy-seven participants from the Texas
clinical center (40 men) age 17 to 63 yr completed two RMR
measurements by indirect calorimetry before training and one
measurement each 24 and 72 h after the last exercise bout.

TABLE 14. RMR before and after the HERITAGE exercise training program.
Pretraining
Resting Metabolic Rate
V̇O2 (mL·min−1)
Men
Women
Total
MJ·d−1
Men
Women
Total
kJ·kg −1 FFM·d−1
Men
Women
Total

Posttraining

Trial 1

Trial 2

Mean

Trial 3: 24 h

Trial 4: 72 h

Mean

253 ± 34
194 ± 29
226 ± 43

249 ± 32
196 ± 29
224 ± 42

252 ± 33
196 ± 31
225 ± 42

255 ± 34
198 ± 33
227 ± 44

253 ± 34
200 ± 32
228 ± 42

255 ± 33
199 ± 31
228 ± 42

7.32 ± 0.97
5.62 ± 0.83
6.56 ± 1.24

7.25 ± 0.94
5.69 ± 0.91
6.51 ± 1.21

7.31 ± 0.95
5.70 ± 0.89
6.54 ± 1.22

7.37 ± 0.98
5.74 ± 0.95
6.56 ± 1.26

7.35 ± 0.98
5.80 ± 0.92
6.61 ± 1.23

7.38 ± 0.97
5.78 ± 0.89
6.61 ± 1.23

118.0 ± 11.7
125.9 ± 13.4
121.3 ± 13.0

117.6 ± 14.2
126.8 ± 14.2
121.3 ± 14.6

118.0 ± 12.6
127.2 ± 13.4
121.8 ± 13.8

117.1 ± 12.1
125.5 ± 13.4
121.3 ± 13.4

116.7 ± 14.6
128.9 ± 13.4
121.8 ± 15.1

117.2 ± 13.0
127.2 ± 12.1
121.8 ± 13.4

Mean ± SD. Maximum number of subjects: 40 men and 37 women. No significant effect of the training program was found on RMR expressed various ways.
Reproduced with permission from Wilmore et al. (153).
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CANDIDATE GENE AND GWAS STUDIES
Genetic studies of exercise-related traits at the genome level
in HERITAGE began in 1997 and have been characterized by

several phases that closely matched advances in genomic technologies. The first wave of studies focused on candidate genes.
It was followed by a series of reports based on an unbiased
search of the genome using panels of microsatellite markers
and linkage analytical strategies, which led to positional cloning
and fine mapping of regions of interest. In a next phase, sets of
candidate genes were uncovered by probing the variability in
skeletal muscle gene expression, which were then submitted
to further investigation. Finally, in more recent times, millions
of single nucleotide polymorphisms (SNPs) covering the
whole genome are being used in association studies of HERITAGE traits. A brief summary of the findings across these approaches follows.
Candidate gene studies. A total of 37 studies published
between 1997 and 2010 tested associations between 34 candidate genes and a wide variety of traits measured at baseline
and in response to training. The phenotypes investigated included cardiorespiratory fitness traits (maximal and submaximal V̇O2 and PO), hemodynamic-related traits (resting and
submaximal exercise HR, SBP and DBP, and submaximal
SV and Q̇), adiposity-related traits (BMI, sum of eight skinfold
thicknesses, FM, percent body fat, and abdominal fat), plasma
lipid and lipoprotein traits (TC, TG, LDL-C, HDL-C, and apolipoproteins), and insulin and glucose metabolism traits
(fasting glucose, insulin and C-peptide levels, Si, AIRg, and
Sg). In most studies, the association with baseline and

TABLE 15. Summary of candidate gene studies with baseline (B) and response (R) traits in HERITAGE.
Gene Symbol
ACE
ADIPOQ
ADRA2A
ADRB2
ADRB3
AGRP
AGT
AMPD1
ANG
APOE
ATP1A2
BCHE
CETP
CKM
DRD2
EDN1
FHL1
FTO
GHRL
GNB3
LEP
LEPR
LIPC
LIPE
LPL
MC4R
NOS3
PON1
PPARG
PTPN1
SLC4A5
TGFB1
TNF
UCP3

Gene Name

CRF

Angiotensin I converting enzyme
B and R
Adiponectin, C1Q and collagen domain containing
Adrenoreceptor alpha 2A
Adrenoreceptor beta 2
Adrenoreceptor beta 3
Agouti related neuropeptide
Angiotensinogen
Adenosine monophosphate deaminase 1
B and R
Angiogenin
Apolipoprotein E
R
ATPase Na+/K+ transporting subunit alpha 2
Butyrylcholinesterase
Cholesteryl ester transfer protein
Creatine kinase, M type
B and R
Dopamine receptor D2
Endothelin 1
Four and a half LIM domains 1
FTO alpha-ketoglutarate dependent dioxygenase
Ghrelin and obestatin prepropeptide
B
G protein subunit beta 3
Leptin
Leptin receptor
Lipase C, hepatic type
Hormone-sensitive lipase
Lipoprotein lipase
Melanocortin 4 receptor
Nitric oxide synthase 3
Paraoxonase 1
Peroxisome proliferator–activated receptor gamma
R
Protein tyrosine phosphatase nonreceptor type 1
Solute carrier family 4 member 5
B
Transforming growth factor beta 1
Tumor necrosis factor
Uncoupling protein 3

Hemodynamic Adiposity Lipids and Lipoproteins Insulin and Glucose

Other

R

B and R
B and R
B

B
B
B and R
R
B
B

B

B

Dietary intake

B and R
Anxiety
B and R
PA level
R
B and R

R

B and R
B
R
R
R
R

B
B
B
B
R

Anxiety
B and R
B

R
B

B
B
CRP B and R
R

References
(172,173)
(174)
(175)
(176,177)
(177)
(178–180)
(172,181)
(182)
(183)
(184,185)
(186)
(187)
(185)
(188)
(189)
(190)
(191)
(192)
(193)
(194)
(195)
(195,196)
(197)
(198)
(199)
(200)
(201)
(187)
(202,203)
(204)
(205)
(206)
(207)
(208)

An entry indicates that at least one trait showed significant (P < 0.05) evidence of association with a variant in the gene locus. Gene symbols and names are from the National Center for
Biotechnology Information.
CRF, cardiorespiratory fitness; PA, physical activity.
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Identical RMR testing procedures were used for each test
(153). Reliability was high (intraclass correlation ≥0.90) between the two pretests, including resting V̇O2, resting energy
expenditure, HRsleep, and HRRMR.
There was no change in RMR due to training at 24 or 72 h
after training. Adjusting RMR values for age, sex, fat-free mass,
and pretraining V̇O2max did not affect the results (Table 14). There
was a large pretraining to posttraining increase in V̇O2max (17.9%)
and small but significant differences in HRsleep, (61.0–59.3 bpm),
HRRMR (60.7–58.7 bpm), percent body fat (29.2%–28.2%), FM
(23.1–22.5 kg), and fat-free mass (54.3–55.0 kg) in this subsample.
The effect of aerobic training has continued to be a topic of
interest, with most studies since the 1998 HERITAGE publication showing that aerobic training does not affect RMR
(154–166). One study showed that White women did not experience a change in RMR after 6 months of training, whereas
Black women saw a decrease (167). Another study showed an
increase at 7 wk, but a return to pretraining levels after 14 wk
of training (168). Three studies have shown an increase in
RMR with aerobic training (169–171). There is no clear explanation for these apparent differences.
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response traits was tested in Black and White subjects, and the
associations tended to be ethnic specific. Table 15 summarizes
the findings by indicating whether an association was reported
at baseline (B) or in response to training (R) for any given phenotype in each trait category.
For cardiorespiratory fitness and hemodynamic-related traits,
ACE, AGT, AMPD1, ANG, ATP1A2, CKM, GHRL, GNB3,
NOS3, PPARG, and SLC4A5 showed evidence of association,
with at least one phenotype measured at baseline or in response to training. For example, one of the first candidate gene
studies showed that muscle-specific creatine kinase (CKM), a
gene previously related to intrinsic cardiorespiratory fitness,
was associated with response of V̇O2max to training adjusted
for age, sex, BMI, and pretraining V̇O2max, but not baseline
levels of V̇O2max in White subjects (188). A later study found
that, in Black subjects, minor allele homozygotes (T/T) at
PPARG rs2016520 showed smaller training-induced improvements in V̇O2max than C-allele carriers (202). Several candidate
genes, ADIPOQ, ADRA2A, ADRB2, AGRP, AGT, FTO, GHR,
GNB3, LEPR, LIPE, PTPN1, and UCP3, showed evidence
of association with at least one adiposity-related trait.
However, no association was found between polymorphisms in the ADRB3 and MC4R genes and adiposity. Minor allele homozygotes (A/A) at FTO rs8050136 were heavier
and fatter in White men but not White women, whereas C allele carriers showed three times greater reductions in FM and
percent fat than A/A homozygotes across all White subjects
(192). These findings suggest that resistance to traininginduced reductions in adiposity is one mechanism by which
FTO is related to obesity.
For lipid and lipoprotein traits, evidence of association was
found with these candidate genes: ADIPOQ, APOE, CETP,
LIPC, LPL, and PPARG. The APOE polymorphism was associated with baseline lipoprotein levels, with the E2/3 genotype
having the lowest and E3/4 and E4/4 genotypes the highest
LDL-C levels in men and women of both ethnic groups. White
female carriers of E3 had higher baseline HDL-C levels, and
White female carriers of E2/3 and E3/3 showed larger increases
in HDL-C in response to training than E4/4 carriers (184). A
subsequent study showed that CETP genotypes and haplotypes
were associated with HDL phenotypes, including that CETP
rs1800775 A/A homozygotes had higher baseline HDL-C levels
in both Blacks and Whites and greater increases in HDL3-C and
apoA-I with training in Whites only (185). Combined models
found that the APOE and CETP rs1800775 genotypes accounted
for 6%–9% of the variance in baseline and training-induced
changes in apoA-I and HDL phenotypes. For traits related to insulin and glucose metabolism, evidence of association was observed with ADIPOQ, FHL1, LEP, LEPR, LIPC, PPARG, and
PTPN1. For example, an association was observed between
DNA sequence variation in the FHL1 gene and the response of
fasting insulin and insulin sensitivity to training in White men
(191). Evidence of a gene-training interaction was uncovered,
with PPARG Ala carriers displaying greater improvements in
glucose (Kg, Sg) and insulin (AIRg, Di) metabolism in response
to training (203).
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BP phenotypes were linked to several candidate genes (ACE,
AGT, AMPD1, ANG, EDN1, GNB3, NOS3, SLC4A5, TGFB1).
The relationship between variants in angiotensinogen (AGT
M235T, rs699) and angiotensin-converting enzyme (ACE insertion/deletion) and training-induced changes in resting and exercise BP was studied in 476 Whites from 99 families. It was found
that men with the AGT MM and MT genotypes demonstrated
improved DBP responses to training, whereas men with the TT
genotype had minimal responses and, moreover, had significantly higher DBP responses during acute maximal exercise
(172). In a sample that included both ethnic groups of HERITAGE, an angiogenin (ANG) gene polymorphism was associated with both pretraining and posttraining resting and exercise
SBP among Blacks, but not Whites (183). These findings extended previously known associations between ethnicity and resting BP to exercise BP responses. Subsequently, a polymorphism
in the transforming growth factor-beta (TGF-β) gene was associated with SBP at rest and during acute exercise both before and
after the exercise program among Whites, but not Blacks (206).
Data from the Aerobics Center Longitudinal Study and HERITAGE were used to examine the association of endothelin 1
(EDN1) SNPs and BP phenotypes. In a case–control study design of incident hypertension, the investigators found that, although the allele and genotype frequencies of EDN1 tagging
SNPs were not different between the two groups, there was a significant interaction between the EDN1 rs5370 genotype and
baseline cardiorespiratory fitness levels on the future risk of hypertension. The EDN1 rs5370 risk allele (T) was also associated
with attenuated responses in SBP and pulse pressure after training in HERITAGE White subjects, highlighting the capacity
for physical activity and fitness status to potentially modify the
influence of genes on cardiovascular outcomes (190).
Other studies found evidence of associations between genetic variation in BCHE and PON1 genes and anxiety scores
(187), DRD2 gene and physical activity level (189), TNF gene
and C-reactive protein (CRP) levels (207), and AGRP with total dietary and macronutrient intake (178).
Genome-wide linkage studies. Before the advent of
GWAS to identify loci associated with complex traits, genomewide linkage analysis (GWLA) was a common unbiased method
used to identify regions of the genome (known as quantitative
trait loci or QTLs) harboring genes that could influence complex
traits. In HERITAGE, 23 GWLAs were undertaken to identify
QTLs associated with traits measured at baseline or in response
to training. For these linkage scans, up to 700 markers covering
the 22 autosomes with a mean spacing of 4.1 Mb on the physical
map were used. In these studies, the sibpair linkage method was
used to test for linkage between the phenotype of interest and
microsatellites, a class of highly polymorphic genetic markers
consisting of variable copy number of repetitive DNA sequences
found in the noncoding regions of the genome. Typically, multipoint
linkage analysis was performed using a regression-based
model, as implemented in MERLIN (81). Briefly, siblings
who share a greater proportion of alleles identical-by-descent
at the marker locus will also show a greater resemblance in the
phenotype. The phenotypic resemblance of the siblings is linearly
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these SNPs showed phenotypes compatible with alterations with
glucose metabolism (238).
HERITAGE involvement in large GWAS consortia.
HERITAGE joined the GIANT (Genetic Investigation of ANthropometric Traits) and CHARGE consortia, international
collaborative efforts aimed at identifying genetic loci associated with human body size, obesity, and behavioral and physiological traits. The primary focus of these large-scale projects
has been meta-analysis of GWAS data. The GWAS data from
HERITAGE Whites (n ~ 483) have been included in GWAS
meta-analyses of obesity (239), height (240), BMI (241,242),
and traits related to body shape/composition (waist circumference,
waist-to-hip ratio, body fat percentage) (243–246). HERITAGE
also contributed to GWAS meta-analyses of HR (247), plasma
leptin (248), dietary macronutrient intake (249), and principal
components of anthropometric traits (250).
These meta-analyses involved up to hundreds of thousands
of individuals from dozens of studies, with genotype data on
tens of thousands to millions of SNPs. For example, in one
of the largest GWAS meta-analyses of BMI, 339,224 individuals were included from 80 studies in stage 1 and another 34
studies in stage 2 and found 97 BMI-associated loci (P < 5 × 10−8)
(241). Conversely, a study of the influence of age and sex on
genetic associations with body size and shape examined up
to ~2.8 M SNPs in over 320,000 individuals (246). A number
of these efforts have dealt with potential interactions with
smoking, sleep, or educational attainment. One report investigated genome-wide lipid loci stratified by sleep duration
(251), whereas another searched for loci related to resting
BP and sleep (252). The smoking by genotype interactions on
the risk of type 2 diabetes and fasting plasma glucose was considered in a recent study (253). Finally, the potential interactions with
level of education were investigated for genome-wide loci associated with resting BP (254). This series of gene–environment
interaction reports has successfully identified new genomic
loci relevant to plasma lipids, blood glucose, and BP.
These GWAS meta-analyses are among the most cited articles in the fields of genetic epidemiology and obesity genetics
and have contributed greatly to our understanding of the genetic architecture of anthropometric traits in adults.
Genome-wide interaction studies. Understanding the
genetic and environmental factors and their interactions (G × E)
underlying complex disease traits may provide insights into
more effective intervention and therapeutic strategies. More recently, a major initiative was launched to pursue genome-wide
interaction studies (GWIS) (255). Several GWIS reports identified important gene–lifestyle interactions for several cardiometabolic traits (243,246,256–262). The HERITAGE study investigators participated in most of these GWIS investigations,
which contributed novel findings.
For example, several loci showing strong evidence for regulatory features supporting shared pathophysiology between
cardiometabolic and addiction traits, such as smoking, were
identified (262). GWIS reports have also highlighted a role
in BP regulation for biological candidates such as modulators
of vascular structure and function (CDKN1B, BCAR1-CFDP1,
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regressed on the estimated proportion of alleles that the sibling
pair shares identical-by-descent at each marker locus (209).
The first HERITAGE GWLA undertaken on baseline V̇O2max
and its response to training led to the identification of four QTLs
for baseline V̇O2max and five QTLs for V̇O2max response (210).
Several other QTLs for traits related to cardiorespiratory fitness
(211,212), hemodynamic phenotypes (213–218), adiposity
(219,220), plasma lipids and lipoproteins (221,222), sex hormones and steroids (125,126), insulin and glucose metabolism
(223–225), energy and macronutrient intake (226), CRP levels
(227), and metabolic syndrome (228) have been identified.
Two bivariate GWLAs were also undertaken to identify pleiotropic QTLs affecting adiposity and TG levels (229) and TG
and HDL-C levels (230). Results suggested that one or more
QTLs in the 19q13 region jointly influence TG levels and adiposity, with the APOE and LIPE (hormone-sensitive lipase)
genes being strong candidates for the source of the pleiotropic
QTL (229). Dense mapping of three QTLs associated with the
changes in submaximal exercise (50 W) SV (2q31-q32 and
10p11.2) and HR (2q33.q34) led, respectively, to the identification of the titin (231), kinesin family member 5B (232), and
cAMP responsive element binding protein 1 (233) genes as
strong candidate genes for hemodynamic responses to training.
A QTL for submaximal exercise capacity (V̇O2 at 60% V̇O2max)
on 13q12 was followed by dense mapping with more than 1800
SNPs over a 7.9-Mb region (211). Association analyses narrowed
the target region to loci encoding MIPEP and SGCG.
Genome-wide association studies. To date, five GWAS
based on HERITAGE data have been published. The first GWAS
examined the association of 324,611 SNPs with V̇O2max response
to endurance training and identified a panel of 21 SNPs explaining
about half of the variance in the trainability of V̇O2max (234). A
second GWAS revealed that nine SNPs accounted for the genetic
variance of the submaximal exercise HR response to training
(235). A third study performed genome-wide and transcriptomewide profiling to identify genes associated with the TG response
to training (236). The GWAS identified four SNPs accounting
for the genetic variance of the TG response, whereas a molecular
signature based on the baseline expression of 11 genes predicted
27% of TG changes in response to training. Association analyses
of SNPs in or near these 11 predictor genes revealed that SNPs
from only four genes were associated with TG changes. A
composite score based on the top four SNPs, each from the
genomic and transcriptomic analyses, was found to be the
strongest predictor of the TG response to training in a model
including over 50 clinical predictor variables (236). A fourth
GWAS based on data from three different cohorts including
HERITAGE identified 52 SNPs from 7 loci showing suggestive evidence of association (P < 1.0 × 10−6) with AVF and subcutaneous fat assessed by CT scan (237). A fifth GWAS
revealed associations between SNPs and insulin sensitivity (Si).
More specifically, the GWAS analysis identified one SNP significantly associated with baseline Si (P = 3.79 × 10−8) plus 7 SNPs
with suggestive association (P < 10−5), and 10 SNPs with suggestive association (P < 10−5) with Si response to training. Interestingly, mouse knockouts in four of the genes associated with
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PXDN, EEA1), ciliopathies (SDCCAG8, RPGRIP1L), telomere
maintenance (TNKS, PINX1, AKTIP), and central dopaminergic
signaling (MSRA, EBF2). Similarly, analyses of gene–smoking
interactions in lipids have identified several new loci associated
with lipids, some of which were detected only in smokers,
thereby highlighting the importance of gene–behavior interactions (256). Despite some interesting findings, it is still unclear
how prevalent such interactions are and what their full impact
may be on the genetic and environmental architecture of complex traits. Only comprehensive and properly powered GWIS
studies can address these uncertainties.

GENE EXPRESSION STUDIES
A subset of HERITAGE participants from the Quebec clinical center underwent vastus lateralis skeletal muscle biopsies
to examine the association between the muscle gene expression profile and cardiometabolic phenotypes at baseline and
in response to training.
A first study examined muscle gene expression in 16 subjects discordant for the response of insulin sensitivity (Si) to
the training program: 8 showing no changes (low responders)
and 8 showing marked improvements (high responders; response ~4 times higher than that of low responders) (263).
Differences in gene expression before and after training were
tested for 703 and 1166 transcripts, respectively, using pooled
RNA from each group. A total of 38 transcripts were differentially expressed between response groups at both baseline and

posttraining, with 22 having known functions: upregulated
genes were related to cell adhesion/growth, signal transduction, and electron and adenine transport, whereas downregulated genes were involved with oxidative phosphorylation,
transcript regulation, and protein biosynthesis. Differential expression at either baseline or posttraining was confirmed by
real time quantitative reverse polymerase chain reaction in four
of the five genes selected for validation (Fig. 6) (263). In a
follow-up report on three SNPs at the FHL1 locus, one of these
four genes, it was found that allelic variants were associated with
changes in fasting insulin, Si, Kg, and Di response to training in
White men (191). Further analysis of the relationship between
gene expression and Si was examined in a study where a transcriptional signature linked to the transcription factor MEF2A
was found to be predictive of the response of Si both in HERITAGE and in an independent cohort (238).
HERITAGE gene expression data were also used in a study
that identified an age-related gene expression signature in human muscle (264). Using a total of 97 Affymetrix U133 + 2
gene chips from two independent studies, including 52 from
HERITAGE, 580 genes were identified whose expression levels
were related to a continuum of age (18–78 yr). The muscle
age-related genes were related to serotonin, DNA topoisomerase antagonism, and RXR activation.
In one study, a combination of genome-wide muscle gene
expression with DNA sequence variation screening was
used to identify genes associated with changes in V̇O2max
due to endurance exercise training (265). A regression

FIGURE 6—Real time quantitative reverse polymerase chain reaction validation of gene expression levels for insulin sensitivity (Si) response to training
identified in microarray experiments. HSIR, high Si responder; LSIR, low Si responder; PDK4, pyruvate dehydrogenase kinase 4; TTN, titin; SKI, V-Ski avian
sarcoma viral oncogene homolog; FHL1, four-and-a-half LIM domain 1. Levels normalized over the corresponding 18S rRNA value. *P < 0.05 for difference in
mean value between response groups. Adapted with permission from Teran-Garcia et al. (263).
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an mTor-independent mechanism regulating metabolic adaptation. Analysis of the Eif6+/− haploinsufficient mouse (50% reduction in eIF6 expression) found different transcriptional profiles compared with wild-type mice (genes differentially expressed
in the gastrocnemius: 2651 upregulated, 829 downregulated;
soleus: 2482 upregulated, 1846 downregulated; tibialis anterior: 1361 upregulated, 958 downregulated; false discovery
rate < 10%) and that the profile of the gastrocnemius muscle
mirrored the predicted Eif6 signature found in HERITAGE
both in functional profile and in direction of change. Further experiments of mitochondrial functionality and muscle performance in Eif6 heterozygote mice revealed alterations in electron
transport chain dynamics, superoxide generation, and reduced
exercise capacity, further supporting the role of this factor in
regulating muscle energy homeostasis (267).
Finally, a study that utilized transcriptome-wide profiling to
identify a baseline muscle gene expression signature of the response of TG to training was described previously (236). Briefly,
after transcriptome-wide association analysis, a molecular
signature based on the baseline expression of 11 genes predicted
27% of TG changes in response to exercise training (Fig. 7).

METABOLOMIC STUDIES
Targeted, liquid chromatography tandem mass spectrometry–
based metabolomics was performed to profile 186 plasma metabolites in 441 White subjects before and after training. DMGV, a
recently identified circulating biomarker of liver fat that predicts
incident type 2 diabetes and decreases in body weight after
weight loss surgery (268), was investigated to examine its
relationship to cardiometabolic changes with training (96). In
age- and sex-adjusted analyses, baseline DMGV levels were

FIGURE 7—Performance of the vastus lateralis gene expression profile regression model derived from a training set (n = 37, gray dots) and a validation set
(n = 12, red dots) for the prediction of exercise training-induced changes in TG in HERITAGE. Reproduced with permission from Sarzynski et al. (236).
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analysis combining SNPs associated with 29 skeletal muscle transcripts predicting changes in V̇O2max and SNPs previously associated with the trainability of V̇O2max led to the
identification of a set of 11 genetic variants explaining 23% of
the variance in V̇O2max training response. Subsequently, regulatory molecules coordinating the complex network of ~800 genes
found to be differentially regulated in response to training
(i.e., training-responsive transcriptome) were examined by
contrasting subjects who demonstrated the least versus the
greatest improvement in V̇O2max (low vs high responders)
resulting in the identification of 86 genes (266). A panel of
3400 SNPs near these 86 genes were genotyped, and 24 were
nominally associated with responder status (P < 0.01) but not
statistically significant after accounting for multiple testing: 8
of them belonged to the HLA cluster of genes on chromosome
6, whereas other significant SNPs were in loci coding for proteins largely involved in cell proliferation or tumor suppression (ASNS, DLC1, FABP5, NID1, PDZD2, SASH1, SPARC,
and TRAM1 genes).
A data-driven, reverse-engineering approach was used to develop a genome-wide network model of muscle homeostasis in
response to training (267). The analysis initially focused on
identifying pairs of genes that were differentially coexpressed
between pretraining and posttraining skeletal muscle in HERITAGE (n = 52). The analysis identified a differential
coexpression network, which the algorithm organized into 25
interconnected gene clusters. Further analysis of the inferred
network revealed that genes found within core metabolic and
translational pathways are a predominant feature of these networks. Interestingly, the eukaryotic translation initiation factor
Eif6 was the most connected ribosome associated factor in the
network leading to the hypothesis that Eif6 could be a part of
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FIGURE 8—Associations between baseline DMGV levels and HDL traits responsiveness to exercise training in HERITAGE Whites. Reproduced with permission from Robbins et al. (96).

positively correlated with adverse body mass and composition
(including visceral fat), lipid and lipoproteins, and glucose and
insulin homeostasis traits (β coefficient ranges for associations
meeting Bonferroni statistical significance: 0.17–0.46). After
adjustment for both BMI and AVF, associations of DMGV
levels with all glucose and insulin traits and 16 of 22 lipid metabolism traits remained highly significant (96). DMGV levels
decreased with training (median change. −9.4%), and changes
in DMGV were positively correlated with changes of several
lipid and glucose and insulin traits (e.g., total, medium, and
large VLDL-P; VLDL-P size; TG; total and medium HDL-P;
small LDL-P, TC; fasting insulin and glucose).
Baseline levels of DMGV were associated with attenuated
improvements in HDL traits (inverse association with total
and medium HDL particle concentration and apoA-I; positive
association with small HDL particles) after training, even after
adjusting for age, sex, baseline level of each outcome variable,
and changes in BMI and visceral fat (96) (Fig. 8). Baseline
DMGV levels were also inversely associated with changes in
Si (β = −0.13; P = 3.0 × 10−3) and positively with changes
in AVF (β = 0.11; P = 0.03) and body mass (β = 0.11;
P = 0.04) in minimally adjusted models, but the associations
were not significant in fully adjusted models. In summary,
DMGV identified adverse metabolic traits in healthy adults of European descent in HERITAGE and was associated with attenuated
improvements in lipid traits and insulin sensitivity with training.

PROTEOMIC STUDIES
The most recent molecular profiling platform applied to HERITAGE has been proteomics. Specifically, to measure large-scale
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circulating proteomic changes after endurance exercise training,
baseline and posttraining plasma samples were analyzed using
the Slow-Off rate Modified Aptamer (SOMAmer)-based platform, SomaScan® (SomaLogic, Inc., Boulder, CO). This platform utilizes affinity binding to quantify approximately 5000
distinct protein targets in circulation (269,270).
In a novel, proof-of-concept study utilizing SomaLogic
proteomics data, the association of plasma proteins with
cross-sectional V̇O2max was analyzed (271). An unpaired
crossover sampling method (with 50% of samples from subjects at baseline and 50% at posttraining) was used to avoid
correlation from pairs and to increase the observed range of
V̇O2max values in the data set. An elastic net linear regression model was derived, refined, and validated on 80%,
10%, and 10% of participants, respectively. The derivation
model (80%, or 523 subjects) identified 115 proteins that were
highly correlated with measured V̇O2max, with an r2 of 0.80;
this was replicated in the validation data set (10%, or n = 62),
with an r2 of 0.71 (Fig. 9). The top 3 proteins with the largest
quantitative contribution to V̇O2max were leptin, C1QR1 (complement component C1Q receptor, part of immune system),
and GGH (gamma glutaryl hydrolase, regulation of intracellular folate) (271).
The plasma proteomic profile of V̇O2max was further refined
in analyses that characterized proteins associated with baseline
V̇O2max and changes in V̇O2max in response to training in more
than 650 subjects (272). After adjustment for age, sex, BMI,
and ethnicity, 147 circulating proteins were associated with
baseline V̇O2max (Fig. 10, left panel), including 85 proteins
that were positively associated and 62 proteins negatively associated. Proteins positively associated with baseline V̇O2max
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FIGURE 9—Prediction of measured V̇O2max by 124 plasma protein levels in the validation data set of HERITAGE. Reproduced with permission
from Williams et al. (271).

spanned specific organ systems and biologic processes including angiogenesis (e.g., extracellular matrix protein 1, anthrax
toxin receptor 2), coagulation and hematopoiesis (e.g., complement decay-accelerating factor, tetranectin), and lipid

metabolism (e.g., apolipoprotein F, lipase member K). Several
well-known markers of metabolic dysregulation known to be
positively associated with adiposity were inversely associated
with baseline V̇O2max, including leptin, CRP, and insulin.

FIGURE 10—Plasma proteins positively and negatively associated with baseline V̇O2max (left panel) and change in V̇O2max (right panel) adjusted for age,
sex, ethnicity, and BMI in HERITAGE. Reproduced with permission from Robbins et al. (272).
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In addition, 102 baseline proteins were associated with
changes in V̇O2max with training in a linear regression model
adjusted for age, sex, BMI, ethnicity, and the baseline level of
V̇O2max (Fig. 10, right panel). Minimal overlap was found between the proteins associated with baseline V̇O2max versus
change in V̇O2max, as only five proteins (T132B, ATF6A,
CO9A1, insulin, and PIANP) were associated with both traits,
proteomic findings that are consistent with clinical findings in
HERITAGE demonstrating a lack of correlation between these
two V̇O2max traits (see the Cardiorespiratory Fitness section).
Subsequently, analyses were aimed at determining the ability
of plasma proteins to identify V̇O2max gains (>15% change
from baseline) to exercise training in comparison to clinical
traits alone. A model based solely on clinical traits (age, sex,
ethnicity, BMI) yielded an area under the curve of 0.62,
whereas the addition of 56 proteins to the clinical trait model
increased the area under the curve to 0.84, a substantial improvement in predicting who is likely to be a higher V̇O2max responder. Lastly, the association of V̇O2max-related proteins with
mortality was examined in the Framingham Offspring Study. It
was found that 12 proteins associated with baseline V̇O2max and
9 proteins associated with change in V̇O2max were associated with
incident all-cause mortality (false discovery rate q < 0.1) (272).

BIOINFORMATICS EXPLORATIONS OF
CARDIORESPIRATORY FITNESS TRAITS
Here, the main findings from integrative bioinformatics explorations of two cardiorespiratory fitness traits representing
intrinsic V̇O2max and trainability of V̇O2max are summarized.
These two studies are separated in time by about 6 yr, and their
methodologies reflect the evolving trends and capabilities of
the bioinformatics field in general.
In 2013, an analysis examining the contributions of genes
and biological pathways to variations in trainability of V̇O2max
(hereafter called delta V̇O2max) was published (273). Using GWAS
SNP associations to delta V̇O2max, significant contributions at
the “gene set” or pathway level instead of individual SNP level
were investigated. By considering association scores from all
gene members of a gene set, pathways related to the broad categories of immune function, cardiomyopathy, extracellular matrix
regulation, and metabolism (PPAR signaling, pantothenate, and
CoA biosynthesis) were found to be significantly associated with
V̇O2max trainability. Examining pathway overrepresentation
among genes above a threshold of genetic association to delta
V̇O2max further identified a network of 35 genes, of which 31
were associated with delta V̇O2max at P ≤ 0.005. These network
genes could be partitioned into pathways related to calcium signaling, nitric oxide signaling, and protein kinase A signaling.
A hypothesis-free gene prioritization tool was used to rank
genes moderately associated with delta V̇O2max in GWAS
analysis. One group of genes (PINX1, CD44, PARK2, RYR2,
ADCY5, and SHANK2) demonstrated consistently strong scores
across all analyses, whereas a second group (KCNQ5, GRIK4,
RPTOR, ACVR1C, and ACSL1) were strongly associated only
in a subset. Several of the genes identified (CAMTA1, RYR2,
ACSL1, CD44, BIRC7/YTHDF1) have been further replicated
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(274). This bioinformatics exploration of the biology underlying
V̇O2max adaptation suggests that pathways related to calcium signaling, energy sensing and partitioning, mitochondrial biogenesis, angiogenesis, immune functions, and regulation of autophagy
and apoptosis are some key mechanisms through which the
physiological responses of V̇O2max to training are mediated.
The bioinformatics explorations of the genetics and biology
underlying V̇O2max in the sedentary state (275) differed extensively in complexity and depth compared with the 2013 analysis of V̇O2max trainability. In the 6-yr interim, there had been
a profound expansion in databases and data analysis tools, especially access to large public data sets and the ability to formulate hypotheses about the function of noncoding SNPs,
thereby greatly expanding the scope of understanding the putative roles of genetic variants. Using summary statistics from
intrinsic V̇O2max GWAS as a starting point, the focus was first
on the “discovery” of candidate genes and pathways, followed by
a “validation” phase of candidate genes identified in the discovery
phase in which knockout phenotypes and exercise cardiovascular
and muscle physiology phenotypes were interrogated (275).
Intrinsic V̇O2max bioinformatics: Discovery phase.
A pipeline consisting of seven steps was used to generate gene
targets and hypotheses regarding the biology underlying V̇O2max.
a. Quantifying gene-level association to intrinsic V̇O2max,
based on SNP data. The most likely causal genes at associated loci were prioritized. This exercise led to the identification of genes such as PRADC1, TPM2, IGFN1, and
CASQ2.
b. Effects of noncoding SNPs on promoter and enhancer
binding sites in key tissues. A statistically significant enrichment for enhancer-associated SNPs was observed in
tissues related to cardiorespiratory functions (aorta, right
ventricle, skeletal muscle, myoblasts, and satellite cells).
The analysis further revealed an increased overlap with
active enhancers (H3K4me1 and H3K27ac marks) and
active promoters (H3K4me3 and H3K9ac marks) in skeletal muscle-related samples, and increased levels of active
enhancer associated H3K4me1-site overlaps in aorta.
These findings provided insights into some possible roles
of regulatory SNPs in influencing intrinsic V̇O2max.
c. Effects of noncoding SNPs on nearby gene expression
(cis-eQTLs) in relevant tissues. A total of 216 SNPs was
found to be significantly associated with cis-gene expression (eQTL P ≤ 1 × 10−05). The top 3 most significant
eQTL associations were observed for SNP rs2838815 regulating ADARB1 gene expression in brain (P ≤ 1 × 10−18),
a cluster of highly linked SNPs (clustered at ATE1 gene
intron) regulating NSMCE4A gene expression in pancreas
(P < 1 × 10−14), and another cluster of tightly linked SNPs
affecting expression of the PRADC1 gene (P ≤ 1 × 10−12)
in adipose tissue, as well as the heart and skeletal muscle.
Analysis for joint effects, that is, genomic loci overlapping
for both eQTL and histone binding sites, demonstrated the
strongest overlaps in heart tissue, followed by the pancreas, skeletal muscle, and adipose tissue.
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Intrinsic V̇O2max bioinformatics: Validation phase.
The prioritized genes were filtered against the evidence available from knockout mouse studies and from new data on intermediate cardiorespiratory fitness endophenotypes available in
HERITAGE.
h. Examining the phenotypic effects of candidate gene
knockouts in mouse models. Knockout mouse phenotype
data from Mouse Genome Informatics were available for
21 of the 38 candidate genes identified through the bioinformatics analyses. Notably, knockout of the Casq2 gene
affected all endophenotype categories (cardiovascular,
hematopoietic, skeletal muscle, metabolism), with most
observed phenotypes related to the cardiovascular system. Knockout of Picalm affected mostly hematopoietic
traits. Sgcg knockout produced effects on cardiovascular
and muscle phenotypes, whereas Pradc1 knockout led to
increased circulating glucose.
i. Examining SNPs in candidate genes for associations to
cardiovascular and muscle intermediate endophenotypes
of intrinsic V̇O2max. Based on the results from the bioinformatics analyses, gene expression studies, and knockout mouse phenotypes, the next step was to investigate
whether candidate genetic loci were associated with
physiological and metabolic traits known to be relevant
to intrinsic cardiorespiratory fitness and measured in HER-
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ITAGE. SNPs in genes such as ADRB1, ATE1, CASQ2,
DMRT2, NOTO, and SGCG were found to be associated
with exercise-related cardiovascular traits such as HR at
60%V̇O2max, SV at 60%V̇O2max, and SBP pressure at
maximal exercise. Multiple SNPs of SGCG, DMRT2,
ADARB1, and CASQ2 genes were nominally associated
with muscle-related traits, including percent fiber type,
capillary area per fiber, and muscle enzyme activities.
As an example, CASQ2 SNP rs7523715 was associated
with Q̇ and HR during submaximal and maximal exercise, respectively, whereas CASQ2 SNP rs2999460 was
associated with the percentage of type 1 and type 2B
muscle fibers. CASQ2 gene expression was also positively associated with enzyme activities related to aerobic
cellular respiration (cytochrome oxidase, CS, and
HADH) and negatively associated with the rate-limiting
enzyme of glycolysis (PFK).
Several candidate genes from the aforementioned integrative analyses provided new insights into the genetic regulation
of intrinsic V̇O2max. Of these, two genes—CASQ2 and SGCG—
are highlighted hereinafter for illustrative purposes. The CASQ2
gene, encoding calsequestrin, a calcium-binding protein localized
in the sarcoplasmic reticulum in cardiac and skeletal muscle
cells, was highly ranked in the bioinformatics analysis, positively correlated in gene expression to intrinsic V̇O2max, harbored SNPs positively associated with several muscle phenotype data from HERITAGE (e.g., greater proportion of type I
and lower proportion of type IIb fibers), while also displaying
knockout mouse phenotypes in all four classes of endophenotypes.
The most notable effects were either cardiovascular (cardiac
muscle contractility, increased heart mass, cardiac hypertrophy, sinus arrhythmia, etc.) or muscle-related (abnormal sarcoplasmic reticulum morphology, reduced muscle contractility).
These findings in HERITAGE corroborate those from a study of
high- and low-active mice in which CASQ1, the muscle form
of CASQ2, was overexpressed in the soleus (primarily comprising type I fibers) of high-active mice compared with
low-active (276). Moreover, transient knockdown of CASQ1
protein in high-active mice resulted in a significant decrease
in physical activity. Rare variant mutations in CASQ2
(rs121434549, rs786205106, and rs121434550) have been implicated in catecholaminergic polymorphic ventricular tachycardia
2 (CPVT2) (277–279). These findings would suggest that common variants in CASQ2 also influence cardiac and skeletal muscle function relevant to intrinsic V̇O2max. Although CASQ2 was
predominantly associated with cardiovascular phenotypes,
the largest number of muscle-related phenotypes was observed
in sarcoglycan gamma (SGCG) knockout mouse models. Notably, SGCG is a sarcolemmal transmembrane glycoprotein and a
component of the sarcoglycan complex linking F-actin cytoskeleton and the extracellular matrix in muscle cells. Impairments in SGCG function result in early-onset recessive muscular dystrophy, especially limb–girdle muscular dystrophy, in
humans (280,281). This study suggests a role for common variations in the SGCG gene in the regulation of intrinsic V̇O2max.
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d. Enrichment of intrinsic V̇O2max-associated candidate genes
in tissue-specific functional networks. The functional connectivity of tissue-expressed genes to the set of GWASsignificant genes was examined. The top 5 tissues with high
network connectivity included the placenta, heart, skeletal
muscle, pancreas, and liver. Analysis of skeletal muscle
specific subnetworks demonstrated a high degree of connectivity for the genes SSB, EED, PICALM, and TIMM8B.
e. Examining skeletal muscle gene expression profiles.
Whole-genome expression profiling data were analyzed
to identify genes that transcriptionally correlated with
intrinsic V̇O2max levels. Forty-seven Affymetrix probes
were significant. Among these, three genes (CASQ2,
COX7A2L, PRADC1) were also identified in our other
bioinformatic analyses.
f. Enrichment of intrinsic V̇O2max-associated genes in biological pathways. Pathway enrichment analysis identified 34
pathways as significant. Hierarchical clustering of the significant pathways identified groups of pathways with shared
genes, for example, pathways involved in calcium and inositol 1,4,5-trisphosphate signaling, and G-protein signaling.
Additional pathway analysis further identified pathways
related to insulin and PI3 signaling as significant.
g. Weighted ranking of candidate intrinsic V̇O2max-associated genes identified in prior steps. To generate a priority
list of candidate genes based on the findings from individual bioinformatics analysis, a weighted-ranking algorithm was developed. The top 10 genes identified through
this exercise included ADARB1, PRADC1, TPM2, FBXO41,
IGFN1, NOTO, CASQ2, ARL6IP5, RAB11FIP5, and TMF1.
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This effort based on a bioinformatics pipeline applied to
V̇O2max data in the sedentary state suggests four gene loci related to cardiovascular physiology (ATE1, CASQ2, NOTO,
and SGCG), four loci related to hematopoiesis (PICALM, SSB,
CASQ2, and CA9), four loci related to skeletal muscle function
(SGCG, DMRT2, ADARB1, and CASQ2), and eight loci related
to metabolism (ATE1, PICALM, RAB11FIP5, GBA2, SGCG,
PRADC1, ARL6IP5, and CASQ2) as candidates for human variability in cardiorespiratory fitness.

EPILOGUE
The HERITAGE Family Study has been a remarkable story
of scientific collaboration among multiple sites and a large
number of scientists, fellows, and research associates over a
period of 30 yr. As with all studies, HERITAGE has strengths
and limitations. Strengths of the study include the relatively
large sample size for an exercise training study, the inclusion
of family members as opposed to singletons, and substantial
samples of both sexes, different ages, and Blacks and Whites.
An extensive panel of quality control measures were implemented to standardize testing and training procedures, staff
training, and minute-by-minute monitoring of each training
session for each participant with a level of compliance reaching
>95%. These efforts included substudies to evaluate withinperson variability over time in sedentary people, and whether
there were between-site differences and drift in testing protocol
over time by clinical center sites. There were extensive panels
of behavioral, physiological, and metabolic phenotypes measured before and after training, with most traits being measured
twice before and then 24 and 72 h after training, all complemented
by a comprehensive data management system and an extensive
biobanking resource.
There are also limitations to the study, the most obvious of
which being the lack of a control group. As mentioned previously, it was agreed 30 yr ago that a control group was not necessary to address the main aims of HERITAGE. Indeed, the

consensus was that the funding available would be better devoted to reaching a larger sample size of families and participants in both ethnic groups than to add a control group. The
lack of a control group became a challenge when the HERITAGE resource was used in secondary analyses. However, a
substantial panel of quality control measures were added to the
protocol in to quantify the assay reproducibility (for bloodbased assays), the reproducibility and technical error of physiological and metabolic measurements, and the within-person variability over time of these traits, plus estimates of between clinical
center differences and drift over time in data, with the goal of
compensating for the lack of a control group in secondary analyses. Other limitations include that only one standardized dose of
exercise was tested, children and older adults were not incorporated into the study, and skeletal muscle samples were available
on only a subsample of participants.
What we have learned has been reviewed in the preceding
sections. The original aims of HERITAGE were to investigate
the magnitude of the individual differences for exercise-related
traits and their response levels with exposure to endurance training, to evaluate whether there was familial aggregation and
compute the heritability level for each trait and their response
to training, and to explore a set of candidate genes and unbiased
genomic microsatellite markers associated with exercise traits
and their trainability. As detailed previously, these aims have
been thoroughly covered across the various phases of the HERITAGE research program. The most novel and impactful findings of the study are summarized in Supplementary Table S4
(Supplemental Digital Content, Appendix, http://links.lww.
com/MSS/C482). An illustration of the general trends in the reported findings is provided here with an emphasis on cardiorespiratory fitness, as evaluated by V̇O2max.
Individual differences in V̇O2max among sedentary adults
were found to be large. An appreciation of their magnitude
can be found in Figure 11. The left panel depicts the distribution of V̇O2max per kilogram of body weight per minute, based
on two tests, within 1 wk, in a group of 174 young adult males

FIGURE 11—Individual differences in intrinsic V̇O2max (left panel) and its response to the standardized training program (right panel) in HERITAGE
young adult males age 17 to 35 yr. Intrinsic V̇O2max is derived from two tests at baseline in the sedentary state. The gain in V̇O2max was calculated using
the mean of two post training values minus the baseline level.
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FIGURE 12—A summary of the correlates of the gains in V̇O2max in response to the standardized and fully monitored 20-wk exercise program of HERITAGE. A maximum of 482 Whites and 259 Blacks were available for these calculations. Age ranged from 17 to 65 yr. The mean gain in V̇O2max was 384 mL
O2 (SD, 202). Reproduced with permission from Sarzynski et al. (33).

age 17 to 35 yr who were all physically inactive (mean of
40.6 mL O2·kg−1·min−1, SD, 8.0). There is a 3-fold range between the low and high values of “intrinsic” cardiorespiratory
fitness. The same observation was made for women, older
subjects, and both ethnic groups. The right panel illustrates
the V̇O2max training response in the same homogenous sample
of young adult males. The mean gain reached 15.7%, with SD
of 8.7%. Even though most tended to improve by about 10%
to 20%, the range of responses is wide, with some experiencing no gain and others improving by 40% to 60%, as illustrated by the skewed distribution. Comparable variability in
baseline levels and responses to training was observed for
other traits, including submaximal exercise capacity, exercise
HR and BP, visceral adiposity, insulin sensitivity, HDL-C, lipoprotein and hepatic lipases, and other exercise-related traits
as was summarized in previous sections of this review.
The topic of familial aggregation and heritability has been
addressed throughout this review. After adjustment for age,
sex, body mass, and other appropriate concomitants, familial aggregation of maximal and submaximal indicators of
cardiorespiratory fitness remained significant, with approximately 2.5 times more variance between families relative
to within families. Familial aggregation for response traits
persisted after adjustment for multiple covariates for the same
traits. Heritability levels commonly reported in the scientific
literature or traits such as body mass and body composition,
fat distribution, visceral fat, BP, insulin and glucose traits,
lipids and lipoproteins were generally replicated in HERITAGE sedentary state measurements. Intrinsic V̇O2max was
characterized by a heritability level of the order of 50% after
adjustment for age, sex, body mass, and body composition.
Globally, the heritability of the training response traits tends
to be lower than the heritability in the sedentary state. One
notable exception to this trend pertains to the trainability of
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V̇O2max, whose heritability level reaches 45% to 50% when
assessed in both the untrained and trained states.
Human heterogeneity in the response to a given dose of exercise over a given time period is deeply rooted in the biology
of human adaptability, with genomic differences playing an
important role. Using the changes in V̇O2max in the HERITAGE
cohort, we have attempted to quantify the correlates and apparent
sources of response variability. Our findings have been summarized earlier and are depicted in Figure 12 (33). Age, sex, ethnicity, baseline body weight, and baseline V̇O2max were all weakly
associated with the gains in V̇O2max, each accounting for 2% to
3% of the variance. The minute-by-minute fluctuations in
achieved HR and PO compared with the prescribed HR and
PO during each exercise session for each subject were computed.
These differences between achieved versus prescribed were
found to account for about 6% of the V̇O2max training response.
We estimated as discussed previously that the measurement error
and the day-to-day variation in V̇O2max explained about 20% of
the variability in training response. Finally, as described earlier
TABLE 16. Correlation coefficients of exercise training responses among cardiometabolic
traits in the HERITAGE Family Study.

V̇O2max
% body fat
AVF
Fasting insulin
HDL-C
Small LDL-P

% Fat

AVF

Insulin

HDL-C

Small LDL-P

GlycA

−0.09

−0.05
0.35*

0.03
0.16*
0.23*

0.06
−0.07
−0.07
−0.09

−0.07
0.08
0.10
0.05
−0.27*

−0.05
0.03
0.08
0.13*
−0.11
0.20*

All listed traits represent the change in trait value in response to training (i.e., delta trait).
Values are Pearson correlation coefficients and (P value). Correlations adjusted for age, sex,
ethnicity, and baseline value of the response traits. Multiple testing corrected threshold for
statistical significance P < 0.007. Based on 564 subjects with complete data.
*P < 0.007 for statistical significance.
Fasting insulin, fasting plasma insulin; GlycA, plasma inflammatory marker; AVF, abdominal
visceral fat; fasting plasma insulin; LDL-P, low-density lipoprotein particle, plasma inflammatory marker GlycA..
Adapted with permission from Barber et al. (283).
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(Fig. 4), the genetic component of V̇O2max trainability accounted
for 47% of the variance, a heritability level compatible with
estimates obtained in selection experiments performed in rats
(282). Thus, in the aggregate, the sources of variation or correlates of V̇O2max trainability explain 87% of the variance, as
detailed in Figure 12 (33).
One important question is whether the HERITAGE findings
on V̇O2max trainability apply to the training-induced changes in
other traits of interest. Individual differences in response level
have been observed for a panel of seven cardiometabolic and
cardiorespiratory fitness traits (44,283). Changes in V̇O2max
were shown to be independent of the changes in adiposity, visceral adipose tissue, insulin, lipid and lipoprotein, and inflammatory phenotype changes (Table 16). For instance, the correlation coefficients between the gains in V̇O2max and the changes
in cardiometabolic traits are less than 0.10. Similarly, the coefficients among several cardiometabolic trait changes are generally about 0.20 or less, except for the changes between percent
body fat and AVF, which reached 0.35 (283). Thus, the response levels across traits do not aggregate in any given individual, indicating that there is a high degree of trait specificity in
responsiveness to an endurance training program. One implication of these observations is that the profile of correlates and determinants for the training-induced gains in V̇O2max is unlikely
to be applicable to other response traits. It is also unlikely that
the underlying biology of training responsiveness (as defined
by molecular drivers, transcription factors, activators and repressors, small and large molecules, gene networks, pathways, and

systems) will be the same for all response traits. Thus, each
response trait or family of traits (e.g., a set of adiposity-related variables) may have its unique biological and molecular signature.
HERITAGE and the early training experiments performed
with numerous pairs of sedentary monozygotic twins have
successfully established that there are considerable individual
differences in the response level to a given dose of exercise of
cardiorespiratory fitness, physiological and cardiometabolic
traits, and that genetic components account for substantial fractions of the response variability. Subsequently, HERITAGE
was the first study to embark on a systematic search for the genomic variants associated with training response variability. Before the GWAS and omics era, multiple candidate genes were
explored, and panels of microsatellite markers were used to perform unbiased screens of the genome taking advantage of the
pairs of siblings and nuclear family structure of HERITAGE
participants. One of the major lessons learned from these early
genetic explorations was that some of the prevailing views during the first 15 yr or so of the HERITAGE research program
were later found to be inadequate. The genetic component of
complex, multifactorial traits, such as V̇O2max trainability or
the training response of any physiological and metabolic trait,
could not be accounted for by a relatively small number of genes
and genomic variants. Advances in technologies and highthroughput systems have allowed the recognition that such complex traits are commonly associated with large numbers of genomic variants, with each of them contributing only a tiny or small
fraction of the genetic variance. Since then, HERITAGE resources

FIGURE 13—Schematic display of the original HERITAGE working model (left side of the figure) and the expanded research strategy deployed to investigate the biology and molecular determinants of exercise-related traits in the sedentary state and their responsiveness to an endurance training program
meeting the requirements of the Physical Activity Guidelines.
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However, in spite of a large number of observational studies, it
is still not clear whether the observed favorable effect of cardiorespiratory fitness depends on the intrinsic level observed in the
sedentary state or if it is mainly driven by the low to moderate
improvements commonly seen with exposures to physical activity (287). The expanded research program of HERITAGE
cannot provide direct evidence in favor of or against either
hypothesis, but it does provide highly relevant information
on the molecular transducers and highly complex biology
of cardiorespiratory fitness and common cardiometabolic
traits in the causal paths linking physical activity, fitness,
and health.
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Displayed in Figure 13 is the contrast between the original
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18 million measured and imputed SNPs), muscle transcriptomic
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SUPPLEMENTARY TABLE S4. Listing of some of the most novel or impactful findings from the HERITAGE Family Study from 1995 to 2021.
Novel or Impactful Findings
Heterogeneity of training responses
Large interindividual differences in
phenotype responses to endurance
training
No correlation between baseline
V̇ O2max and its changes with training

Trait(s)

Details

Citation(s)

V̇ O2max
IVGTT traits

(43,44,74)

No aggregation of training
responsiveness in individuals or
subgroups

V̇ O2max

V̇ O2max responses ranged from no gain to >1 L·min−1 (−5% to +48%).
The proportion of subjects who had no change or decreases in IVGTT
traits ranged from 42% to 55%.
The correlation between baseline and delta V̇ O2max was 0.08, with
baseline levels after adjustments explaining only 2% of the variance in
delta V̇ O2max.
There were low, average, and high V̇ O2max responses across ages, both
sexes, both ethnic groups, and levels of initial V̇ O2max.
Almost half of the cohort had at least one high response and one low
response across seven cardiometabolic traits.
There is a high degree of trait specificity in training responsiveness.
Prevalence of potentially “adverse” response in HERITAGE ranged from
6% to 9% for the four traits.
Within-subject SD from measures repeated days and weeks apart range
from 108 to 137 mL O2·min−1 with CV of 4.1% to 5.0%.
2.7 times more variance between families than within families.
Heritability of intrinsic V̇ O2max was 51%, with significant maternal
heritability (29%).
Maximal heritability estimates ranged from 48% to 70% and 29% to
48% for maternal heritability.
Maximal heritability estimates of 46% for SV and Q at 60% V̇ O2max and
41% and 42% at 50 W
Heritability of 47% to 48%, independent of total body fat

(20,27,33,34), plus
unpublished data
(45)

Heritabilities of SBP and DBP were 68% and 56% in Black subjects vs
43% and 24% in White subjects.
Strong familial aggregation for activities of baseline muscle enzymes
related to PCr, glycolytic, and oxidative metabolism.
Heritability for oxidative stress traits ranged from 31% to 44%.

(56)

V̇ O2max

V̇ O2max, % fat, AVF, insulin,
HDL-C, small LDL, GlycA

Some unfavorable responses to
Fasting insulin;
endurance training
HDL-C; TG; SBP
Familial aggregation of baseline phenotype levels
Within-subject variability
V̇ O2max
Significant familial resemblance for
intrinsic V̇ O2max
Significant familial aggregation for
intrinsic submaximal V̇ O2
Significant familial aggregation for
intrinsic submaximal Q and SV
Significant familial aggregation for
visceral fat
Higher heritability of resting BP in Black
subjects
Significant familial aggregation for
muscle enzyme activities
Significant familial aggregation for
markers of oxidative stress
Familial aggregation of training response
Significant familial aggregation for
V̇ O2max training response
Significant familial aggregation for
submaximal V̇ O2 training response
Significant familial aggregation of
submaximal exercise BP and HR
training responses
Significant familial aggregation for
submaximal Q & SV training
responses
Significant familial aggregation of
interindividual variation in plasma lipid
responsiveness to training

V̇ O2max

V̇O2 at 50 W, 60%, 80%
SV and Q at 50 W and 60%
V̇ O2max
AVF
Resting SBP and DBP
CK, PHOS, HK, PFK, GAPDH,
LPL, CPT, HADH, CS, COX
LDL-ox, C50-AAPH, TBARS,
glutathione

(43)
(283)

(75)

(48)
(58)
(32)

(138,143)
(127)

V̇ O2max

Heritability was 47%, with maternal inheritance accounting for 28%.

(41)

V̇ O2 at 50 W, 60%, 80%

Heritability values ranged from 23% to 57% for the training response of
submaximal measures of V̇ O2.
Heritabilities for HR50, HR60%, and SBP50 responses were 34%, 29%,
and 22%. Heritability for DBP traits and all HR and BP traits were
lower in Black subjects.
Heritabilities ranged from 24% to 38% for SV and Q at 50 W and 60%
V̇ O2max.

(48)

Heritability ranged from 25% to 38% for lipid response traits. Exceptions
were for heritability levels near 60% for changes in apoB in Blacks and
HDL2-C in Whites and a lack of heritability for change in LDL-C in
Black subjects.
Heritability for oxidative stress training response traits ranged from 35%
to 84%.

(98)

HR50, HR60%, SBP50

SV & Q at 50 W and 60%
V̇ O2max
TC, TG, LDL-C, apoB, HDL-C,
HDL2-C, HDL3-C, apoA-I

Significant familial aggregation for
LDL-ox, C50-AAPH, TBARS,
training response of markers of
glutathione
oxidative stress
Significant familial aggregation for
CK, PHOS, HK, PFK, GAPDH,
training response of muscle
CPT, HADH, CS, COX
enzyme activities
Ethnic and sex differences in responses to training
Training responses of submaxmial
HR, SBP, DBP at 50 W
exercise measures of
hemodynamic traits differed by sex
and ethnic groups
a-V̇ O2 diff, SV, Q, and V̇ O2 at
50 W
Significant sex interactions for insulin
sensitivity response to training
Significant ethnic and sex differences in
lipid, lipoprotein, and lipase activity
responses to training

(33,43)

Si
ApoA-I, HDL2-C

LPL activity

Strong familial aggregation was found for training response of muscle
enzymes related to PCr, glycolytic, and oxidative metabolism.

(71)

(58)

(127)

(138,143)

Submaximal HR, SBP, and DBP decreased with training, with greater
reductions in women compared with men and in Black and older
subjects compared with White and younger subjects.
Black men did not increase a-V̇ O2 diff at 50 W. Thus, on average, Black
men had greater increases in SV50 and smaller decreases in Q50
compared with White men to achieve similar VO250.
Insulin sensitivity increased by 10% in the total cohort, with the increase
larger in men than women (16% vs 5%).
ApoA-I increased more in women than men, in Black than White
subjects, and in offspring than in parents. Black subjects
experienced greater increases in HDL2-C compared with White
subjects.
LPL activity increased in all subgroups except Black men.

(17), pp. 10–116

(61), MSSE, pp. 99–106

(74)
(84)

(97)
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Trait(s)

Details

LDL-ox, C50-AAPH, TBARS,
antioxidants, and
aminothiols

Only erythrocyte resistance to hemolysis significantly changed with
training, which interacted with smoking status (smokers did not
experience beneficial effects of training on erythrocytes), and was
significant in women only.
Sample size (N = 77) was larger than previous studies. There was no
change in RMR at 24 or 72 h after training.
Large HDL-P and LDL-P increased, whereas small LDL-P and all VLDL
subfractions and VLDL-P size decreased with training. These
findings were not captured with traditional lipid profiling (i.e., TG
and LDL-C did not change in total sample).

No change in RMR with training.

RMR via indirect calorimetry

Favorable changes in clinically relevant
lipoprotein subfractions in
response to training

NMR-based lipoprotein
subfractions

Genome-wide linkage studies of baseline and response phenotypes
V̇ O2max
Identification of QTLs for baseline
V̇ O2max and for V̇ O2max response
Dense mapping of 4 QTLs identified
SV50, HR50
strong candidate genes for
submaximal exercise capacity and
hemodynamic responses to
training
First GWAS of exercise response traits
V̇ O2max
GWAS of V̇ O2max response to
endurance training
GWAS of submaximal HR response
HR50
to training

Citation(s)

QTLs on 4q, 8q, 11p, and 14q were reported for baseline V̇ O2max. QTLs
on 1p, 2p, 4q, 6p, and 11p were identified for change in V̇ O2max.
Titin, kinesin family member 5B, cAMP responsive element binding
protein 1, MIPEP, and SGCG genes were identified as strong
candidates for changes in submaximal SV and HR and submaximal
exercise capacity.

39 SNPs were associated at P < 1.5 × 10−4, with a panel of 21 SNPs
accounting for 49% of the variance in V̇ O2max trainability.
40 SNPs associated at P < 9.9 × 10–5, with top hit 8 × 10−7. Nine SNPs
accounted for the genetic variance of the submaximal exercise HR
response to training.
Molecular signatures of exercise response derived from integrative analyses of genomic and transcriptomic profiles
V̇ O2max
Genome-wide baseline muscle gene expression and validation identified
Muscle gene expression and SNP
a 29-RNA signature that predicted changes in V̇ O2max. Candidate genes
signatures predict V̇ O2max response to
endurance training
from this predictor and the literature led to a 11-SNP signature that
explained 23% of the variance in V̇ O2max trainability.
Combined genome-wide and
TG
GWAS identified 4 SNPs accounting for the genetic variance of TG
transcriptome-wide analysis
response, whereas molecular signature based on the baseline
identifies SNPs associated with TG
expression of 11 genes predicted 27% of TG changes in response
response to training
to training. An 8-SNP score comprising 4 SNPs each from
transcriptomics and GWAS was the strongest predictor of TG training
response.
GWAS and transcriptional signature of
Si
Integrative analysis of functional genomic and transcriptomic profiles
insulin sensitivity response to
identified combined variation in genes linked to cholinergic,
training
calcium, and chemokine signaling associated with Si training
response. MEF2A transcription factor was the most significant
candidate driving the transcriptional signature associated with Si,
strengthening the relevance of calcium signaling in exercise
training-mediated Si response.
Proteomic signatures of V̇ O2max and its trainability
Elastic net regression identified 115 proteins highly correlated (r2 = 0.80)
Plasma protein signature of
V̇ O2max
with measured V̇ O2max, which was replicated in the validation data
cardiorespiratory fitness level
set, with an r2 of 0.71 (Fig. 9).
147 proteins were associated with baseline V̇ O2max, whereas 102
V̇ O2max
Plasma proteins associated with
baseline proteins were associated with changes in V̇ O2max, with
intrinsic V̇ O2max and its trainability
minimal overlap (only 5 proteins) between protein sets. A baseline
56-protein signature improved prediction of V̇ O2max response (AUC 0.
84) compared with a model of only clinical variables (AUC 0.62).
Bioinformatics explorations of intrinsic V̇ O2max and its trainability
V̇ O2max
Integrative pathway analysis of V̇ O2max
Using GWAS results followed by candidate gene prioritization and
response to training GWAS
pathway analysis, pathways related to calcium signaling, energy
sensing and partitioning, mitochondrial biogenesis, angiogenesis,
immune functions, and regulation of autophagy and apoptosis were
identified as key mechanisms through which the physiological
responses of V̇ O2max to training are mediated.
V̇ O2max
A bioinformatics pipeline applied to V̇ O2max data in the sedentary state
Genetics and biology underlying
suggests 4 loci related to cardiovascular physiology (ATE1, CASQ2,
intrinsic V̇ O2max
NOTO, and SGCG), four loci related to hematopoiesis (PICALM,
SSB, CASQ2, and CA9), 4 loci related to skeletal muscle function
(SGCG, DMRT2, ADARB1, and CASQ2), and 8 loci related to
metabolism (ATE1, PICALM, RAB11FIP5, GBA2, SGCG, PRADC1,
ARL6IP5, and CASQ2) as candidates for human variability in
cardiorespiratory fitness among sedentary adults.
Metabolomic biomarker of training responsiveness
DMGV is a biomarker of metabolic
Fasting glucose, insulin, and
Baseline levels of plasma DMGV associated with lack of improvement
response to endurance training
lipids
in HDL traits. DMGV levels decreased with training and were
positively correlated with several lipid, glucose, and insulin traits
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Novel or Impactful Findings
Response of other traits to training
Little influence of endurance training
on markers of oxidative stress

(153)
(93)

(210)
(211,231–233)

(234)
(235)

(265)

(236)

(238)

(271)

(272)

(273)

(275)

(96)
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